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Degradation in forensic DNA samples, reliable gender determination and inhibition of the 
polymerase chain reaction (PCR) process are the main challenges to DNA typing. Using a 
combination of a Taq mutant polymerase (OmniTaq), EzWayTM PCR Direct Buffer, panel of 
gender determining markers and reduced-size Short Tandem Repeat (STR) primer sets, 
developmental validation using Scientific Working Group on DNA Analysis Methods 
(SWGDAM) guidelines were tested on two miniplexes. Miniplex 1 comprises of the larger STR 
loci in the AmpFlSTR® Identifiler® PCR Amplification kit (D2S1338, D21S11, CSF1PO, 
D7S820, D13S317, TPOX, D18S51, D16S539 and FGA) and three gender markers: sex-
determining region Y (SRY), Amelogenin and DYS392. Miniplex 2 comprises of the remaining 
STR loci (TH01, D19S433, D13S317, D3S1358, D2S1776, D5S818, vWA, D8S1179) and two 
additional STR markers D2S1776 and DYS390. Our results demonstrate that the two miniplexes 
are highly robust in overcoming PCR inhibitors, provide accurate gender determination and 
useful in the analysis of degraded DNA. A novel method of a single amplification/detection of 















1. Forensic DNA Typing 
 
  Forensic science has widely embraced Polymerase Chain Reaction (PCR) based testing 
as the molecular diagnostic tool of choice today.  Technologies used for performing 
forensic DNA analysis have advanced in the last 20 over years. From ABO blood group 
determination, to single-locus and multi-locus probe Restricted Fragment Length 
Polymorphsim (RFLP) methods, the more recent PCR technique has improved in terms 
of processing time and sensitivity and has moved from requiring huge amount of 
biological material with intact DNA, to tiny amounts of sample to yield a complete DNA 
profile (Brettell et al. 2009, Butler, 2006). 
  DNA fingerprinting or DNA typing (profiling) was first discovered in 1985 by a 
Bristish geneticist named Alec Jeffreys who described the repeated DNA sequence 
variations among human individuals which could be used for human identification. The 
basis of these sequence variations among human individuals permits techniques to be 
developed which allows examination of their length variations. These DNA repeats 
regions or minisatellites, became known as variable number of tandem repeats, also 
known as VNTR can range from 9-80 bp. Minisatellites resides in non-coding regions of 
the human genome which could range from 1kb 20 kb in length. The technique to 
examine the length of the repeat sequence varations employed the use of restriction 
enzymes, thereby earning the name of RFLP (Jeffreys et al. 1985). 
  Today, instead of VNTR, short tandem repeats (STRs), also characterised as 
microsatellites, are widely used in human identity testing. These genetic markers contain 
repeated sequences of 2-6 base pairs in length arranged in tandem. STRs are highly 
polymorphic, but with the ease of genotyping by using multiplex PCR (Moretti et al. 
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2001, Lygo et al. 1994 Edwards et al. 1991, Hammond et al. 1994, Budowle et al. 1999) 
they can generate small amplicons that can be rapidly separated in automated detection of 
fluorescent-labeled PCR products after capillary electrophoresis (CE). The small 
amplicon size of STR alleles in contrast to minisatellites also means that STRs are 
suitable in the analysis of degraded DNA commonly encountered in forensic samples 
(Hummel et al. 1999, Alonso et al. 2001, Takahashi et al. 1997, Whitaker et al. 1995, 
Clayton et al. 1995).  
  As a result, this has led to the prevalence of use of STRs in forensic DNA typing. 
Consequently, National DNA databases to assist in criminal and missing persons 
investigation was introduced in several countries, first in the United Kingdom and 
subsequently in United States. Each national DNA database adopts a fixed set of STR 
markers. In the United States, 13 of these STR markers are selected by the Scientific 
Working Group to DNA Analysis Methods (SWGDAM) (Budowle et al. 1998). These 
markers are D8S1179, D21S11, D7S820, CSF1PO, D3S1358, TH01, D13S317, 
D16S539, vWA, TPOX, D18S51, D5S818 and FGA and are used across all federal, state 
and community forensic testing laboratories throughout the United States who contributes 
to their National Databases, also known as the Combined DNA Index System (CODIS). 
These markers that are selected for the US National Database are also known as the 
CODIS core loci. The adoption of the 13 core loci for CODIS in the United States has led 
to commercial companies such as Applied Biosystems (ABI) and Promega to develop 
STR multiplexes that cover these STR makers (Krenke et al. 2002, Holt et al. 2002 and 
Wallin et al. 2002) and has also dictated forensic laboratories in the world to adopt the 
same STRs for use. 
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2. Challenges in forensic DNA typing 
  Forensic DNA analysis has to deal with less than ideal DNA samples. The collected 
biological material, whether in the form of a biological stain from a crime scene, or a 
highly decomposed body from a homicide, are often left exposed in harsh environment 
over prolonged periods of time. In addition, biological material recovered from victims of 
disasters such as from aeroplane crashes, the 2004 Asian Tsunami, the 911 World Trade 
Centre, earthquakes, landslides or incidents of similar nature, are exposed to sudden 
extremities of high heat, moisture and other environmental assaults (Holland et al. 2003, 
Sajantila et al. 1991, Copeland, 1985, Bohnert and Rothschild, 2003). Tiny amounts of 
DNA may also be found in highly putrefied bodies (Hoff-Olsen et al, 1999, Deng et al. 
2005), formalin preserved tissues (Budimlija et al., 2005, Turrina et al. 2008) or hair 
shafts (Pfeiffer et al. 1999). Body fluids such as blood and semen can also be found on 
soil, sand, wood, leaf litter, dyed textile and leather that contain substances which may 
co-extract during DNA isolation and prevent PCR amplification. Therefore, far from 
being preserved in an ideal environment such as a freezer, away from physical, chemical 
and biological elements that can break down the DNA molecules, forensic samples that 
are collected can present challenges on multiple fronts. The major of which are DNA 
degradation, PCR inhibitors and anomalous amelogenin genotypes. 
 
3. Degraded DNA 
  Degradation in forensic DNA samples is a result of environmental exposures, which 
randomly breaks the DNA into fragments. The culprits of DNA degradation include 
water, nucleases or other physical and oxidation processes. When template DNA 
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degradation occurs, the chances of finding a target sequence for both the forward and 
reverse primers to bind simultaneously for full DNA extension during PCR is greatly 
reduced. Without a target DNA that flanks the STR repeat region to serve as template, 
PCR will not be successful because primer extension cannot continue at the break in the 
template DNA. The more the DNA sample is degraded, the more break points occur in 
the target DNA resulting in diminishing DNA targets available having the required length 
for PCR amplification. 
  To address this problem, reduced-size STR primer sets have been designed (Butler et al. 
2003). Multiplexes having these primer sets are known as Miniplexes and the primers are 
designed to bind as close to the repeat region as possible. As commercial multiplex kits 
such as ABI AmpFlSTR® Identifiler® and Promega Powerplex® 16 multiplex kits are 
designed to accommodate multiple markers, a number of primers are designed to 
generate large amplicons, and the primers are required to move further away from the 
core repeat sequence. Therefore, when degraded DNA are encountered, DNA typing 
using commercial multiplex kits result in incomplete or partial DNA profiles, which 
compromise the strength of the DNA evidence for a affirmative identification. The 
redesigned primer sets reduce the amplicons size by requiring smaller DNA targets, 
thereby ensuring greater success in DNA typing. 
  However, the mini-STR strategy has its drawbacks. One of which is the danger of 
placing primers close to the repeat region if insetion/deletions occur in the flanking 
regions of the STR markers but outside of the miniSTR primer binding sites. This will 
result in different allele calls with different primer set or null alleles and this phenomenon 
has been observed in D13S317 (Butler et al. 2003, Boutrand et al. 2001) and D8S1179 
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(Budowle et al. 2001, Han et al. 2001). Another is that a few loci can be simultaneously 
amplified as most of the amplicon spans overlapped between 71 to 250 bp in length. 
Since the amplicon products of mini-STRs will overlap in size more so than those in 
conventional STR kits, the four fluorescent dye label system has since been increased to 
five dyes. This has resulted in more mini-STRs being accommodated into one multiplex 
system. However when a degraded, limited-quantity DNA sample is present, the 
limitation prevents the amplification of adequate STR markers like conventional STR 
kits, which can amplify multiple STR markers in one amplification. Multiple 
amplifications are required to accomplish the same level of discrimination power of 
commercial STR typing kits which routinely co-amplifies 16 markers in one PCR. 
 
4. PCR Inhibition 
  Due to the nature of the forensic samples, the extracted DNA is highly vulnerable to the 
presence of PCR inhibitors from the environment. PCR inhibitors generally exert their 
effects either by direct interaction with DNA or inactivation of Taq DNA polymerase 
thus preventing successful amplification (Wilson, 1997). Direct binding of the inhibitors 
to the DNA can co-purify the inhibitors with the DNA during extraction and prevent PCR 
amplification. Taq DNA polymerase requires Mg2+ as a critical enzyme cofactor and any 
substance that reduce availability of Mg2+ or interfere the binding of Mg2+ to the DNA 
polymerase will inhibit PCR. Important and common source of inhibitors include hematin 
from blood (Akane et al. 1994), humic acid in soil (Tsai and Olson, 1992, Watson and 
Blackwell, 2000), denim, textile dyes (Shutler et al. 1999), tannic acid in leather, 
decomposing vegetitive material, melanin in hair (Echkart et al. 2000), polysaccharides 
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and bile salts in feces (Monteiro et al. 1997) and urea in urine (Mahony et al. 1998). The 
result of amplification in the presence of inhibitor is a loss of the alleles from the larger 
size STR markers or even amplification failures of all STR markers. Samples having 
PCR inhibitors generate partial DNA profiles that look identical to a degraded DNA 
sample.  This is due to smaller PCR products being more efficiently amplified than the 
larger one under inhibitory PCR conditions. 
  There are strategies proposed to overcome PCR inhibitors and reviews of those 
approaches have been published (Wilson 1997, Rådström et al. 2004). PCR inhibitors can 
either be removed or their effects diminished by the following solutions. The target DNA 
can be diluted which also reduce the concentration of the PCR inhibitors, allowing 
amplification. Alternatively, adoption of DNA extraction protocols that efficiently extract 
inhibitor-free DNA such as the use of sodium hydroxide (Bourke et al. 1999), the 
addition of aluminium ammonium sulfate (Braid et al. 2003), or the use of purification 
steps like Centricon-100 and Microcon-100 filters (Comey et al. 1994) and low-melt 
agarose gel plugs (Moreira 1998) have been used to separate the inhibiting compounds 
from the extracted DNA. There are also commercial DNA extraction kits such as Applied 
Biosystems Prepfiler™ or Promega DNA IQ™ that have staked their effectiveness in 
removing PCR inhibitors but these will require extensive validation testing by the 
laboratory. Additives to the PCR reaction, such as bovine serum albumin (BSA) (Comey 
et al. 1994) are found to be able to partially overcome the effects of PCR inhibitors by 
either stabilizing the DNA polymerase or by binding the inhibitors.   Betaine (Al-Soud 
and Rådström 1998) and the single-stranded DNA binding protein of the T4 32 gene 
(Kreader 1996) have also been shown to prevent or minimise the inhibition of PCR but 
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these are inhibitor-specific in nature. Non-Taq DNA polymerase such as rTth, Tfl, 
HotTub and Pwo, can tolerate higher concentrations of blood and feces, which typically 
inhibit PCR when performed with Taq DNA polymerase (Al-Soud and Rådström 1998). 
More recently, alternative DNA polymerases-buffer systems with higher tolerance to 
PCR inhibitors compared to Taq polymerase have been demonstrated (Park et al. 2005, 
Barbaro et al. 2008, Hedman et al. 2009). 
 
5. Amelogenin Deletions 
  Gender identification or gender typing is commonly performed together with STRs in 
commercial kits using PCR products generated only from the amelogenin gene that 
occurs on both the X- and Y-chromosome. A commonly used PCR primer set published 
by Sullivan et al. (1993) targets a 6 bp deletion that occurs on the X-chromosome, which 
results in the X- and Y-chromosome PCR amplicon size to be differentiated from one 
another when electrophoretic separation is performed to separate STR alleles. Since 
females are XX, only a single peak is observed when testing female DNA whereas males, 
which possess both X and Y chromosomes, exhibit two peaks with a standard amelogenin 
test.  However, there have been multiple reports in the literature for anomalous 
amelogenin results due to primer binding site mutations (Roffery et al. 2000, Shewale et 
al. 2004. Shadrach et al. 2004, Alves et al. 2006) or deletions of sections of the Y-
chromosome (Santos et al. 1998, Steinlechner et al. 2002, Thangaraj et al. 2002, Michael 
and Brauner 2004, Lattanzi et al. 2005, Mitchell et al. 2006, Santacroce et al. 2006, 
Cadenas et al. 2007, Chen et al. 2007, Chang et al. 2007, Yong et al. 2007, Jobling et al. 
2007, Kumagai et al. 2008). The results of which could mislead either crime investigators 
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into believing a female perpetuator is involved, or with highly decomposed or fragmented 
or human remains, the gender be falsely identified as a female. The frequency of these 
cases are reported to be low among Caucasians but are found to reach significant levels in 
several other populations (Chang et al. 2003, Lim et al. 2004, Kashyap et al. 2006, 
Chang et al. 2007). With the investigative impact of the gender of a sample so important, 
other additional gender markers e.g. SRY (Santos et al. 1998), DXYS156 (Cali et al. 
2002), Y-STRs (Chang et al. 2007) or alternative amelogenin primer sets (Haas-
Rochholz and Weiler 1997) have been proposed to complement the amelogenin marker.  
6. Aims 
  Given the myriad of challenges that forensic DNA typing analysis possess, our 
laboratory is interested in developing multiplex kits that can simultaneously address the 
problems of DNA degradation, PCR inhibition and anomalous amelogenin typing which 
at present is unavailable in any commercial DNA typing assays. Developmental 
validation studies of the multiplex assay were undertaken in accordance with the 
Scientific Working Group to DNA Analysis Methods (SWGDAM guidelines 
(http://www.fbi.gov/hq/lab/fsc/backissu/july2004/standards/2004_03_standards02.htm).   
These guidelines require a series of tests for the laboratory to assess the limitations of an 
analysis method, and to examine the different parameters that could affect the ability of 
the method to produce reliable results under a variety of conditions (Lygo et al. 1994). A 
series of tests were performed that includes concordance with standard multiplex kits, 
sensitivity, reproducibility and PCR amplification conditions. In addition, studies of 
DNA mixtures, non-human DNA testing, degraded DNA samples and studies involving 
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both simulated forensic samples and casework were covered. This study will cover the 
development strategies employed, and the various tests that are performed as spelt out by 
SWGDAM, which will demonstrate the limits and strengths of this approach to overcome 
the several challenges faced by current forensic DNA typing. Additionally, a novel 
forensic DNA typing strategy is also introduced which enabled more DNA typing results 
when limited highly degraded DNA is encountered. 
  The objective of this project is to develop a method which will benefit justice by 
rendering useful DNA profiles from a significantly high percentage of forensic samples 
in human identity testing, which are challenged by degradation, PCR inhibition and 























1. Design and development of Miniplex 1 and Miniplex 2  
1.1 Locus selection and characterization 
 
  Miniplex 1 (Fig. 1) comprised the larger STR loci in the AmpFlSTR® Identifiler® PCR 
Amplification kit (D2S1338, D21S11, CSF1PO, D7S820, D13S317, TPOX, D18S51, 
D16S539 and FGA) and three gender markers: sex-determining region Y (SRY), 
Amelogenin and DYS392.  Miniplex 2 (Fig 2) comprised the remaining STR loci (TH01, 
D19S433, D13S317, D3S1358, D2S1776, D5S818, vWA, D8S1179) and two additional 
STR markers D2S1776 and DYS390. Both Miniplex 1 and Miniplex 2 have D13S1358 
and serve as a genotype concordance between both Miniplexes to monitor potential 
sample mix-up between amplifications. All the STR markers have been characterised 
extensively for phyisical linkage, Mandelian inheritance, approximation of Hardy-
Weinberg equilibrium and independent assortment (Budowle et al. 1998; Cotton et al. 
2000; Budowle et al. 2001; Hill et al. 2008).   
 
  The PCR primer sequences for the selected STR loci and gender-typing markers were 
taken from published literature (Table 1 and Table 2) and the primers were selected due 
to their design to be as close as the STR target region as possible and termed as miniSTR 
primers (Butler et al. 2003). The exceptions were vWA, D13S317 and SRY. The final 
primers combination in Miniplex 1 and Miniplex 2 were tested for potential binding 
issues with each other using AutoDimer (Vallone and Butler, 2003). All of the forward 
primers were labeled with either 6FAMTM (blue), VIC® (green), NEDTM (yellow), or 
PETTM (red) fluorescent dyes, and with the LIZ® dye used to label the GeneScanTM-500 
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Figure 1. Schematic layout of Miniplex 1 kit for a single amplification of 10 autosomal STR markers, 1 Y-STR marker 





      
Figure 2. Schematic layout of Miniplex 2 kit for a single amplification of 8 autosomal STR markers and 1 Y-STR marker. 






Name   
Forward 
Dye Label PrimerSeq(5'to3') 
Primer 
Concentration, µM Reference 
SRY F 6-FAM GTATCGACCTCGTCGGAAG 0.5 This study 
 R  GAGTACCGAAGCGGGATCT 0.5 This study 
Amelogenin F 6-FAM CCTTTGAAGTGGTACCAGAGCA 0.5 Haas-Rochholz and Weiler, 1997 
 R  GCATGCCTAATATTTTCAGGGAA 0.5 Haas-Rochholz and Weiler, 1997 
D2S1338 F 6-FAM TGGAAACAGAAATGGCTTGG 0.5 Butler et al., 2003 
 R  CATTGCAGGAGGGAAGGAAG 0.5 Butler et al., 2003 
D21S11 F 6-FAM ATTCCCCAAGTGAATTGC 7.25 Butler et al., 2003 
 R  GGTAGATAGACTGGATAGATAGACGA 7.25 Butler et al., 2003 
DYS392 F 6-FAM ACCTACCAATCCCATTCCTT 1 This study 
 R  ATTCTGTAAATGGTTGTATAGTATTTTATG 1 This study 
CSF1PO F VIC ACAGTAACTGCCTTCATAGATAG 1 Butler et al., 2003 
 R  GTGTCAGACCCTGTTCTAAGTA 1 Butler et al., 2003 
D7S820 F VIC GAACACTTGTCATAGTTTAGAACGAAC 0.5 Butler et al., 2003 
 R  ATTTCATTGACAGAATTGCACCA 0.5 Butler et al., 2003 
D13S317 F VIC GGCAGCCCAAAAAGACAGA 0.25 Krenke et al., 2002 
 R  ATTATTATTACAGAAGTCTGGGATGTGGAGGA 0.25 Krenke et al., 2002 
TPOX F NED CTTAGGGAACCCTCACTGAATG 1 Butler et al., 2003 
 R  ATTTTGTCCTTGTCAGCGTTTATTTGC 1 Butler et al., 2003 
D18S51 F NED TGAGTGACAAATTGAGACCTT 0.5 Butler et al., 2003 
 R  ATTATTGTCTTACAATAACAGTTGCTACTATT 0.5 Butler et al., 2003 
D16S539 F PET ATACAGACAGACAGACAGGTG 3 Butler et al., 2003 
 R  GCATGTATCTATCATCCATCTCT 3 Butler et al., 2003 
FGA F PET AAATAAAATTAGGCATATTTACAAGC 4 Butler et al., 2003 
 R  GCTGAGTGATTTGTCTGTAATTG 4 Butler et al., 2003 





Miniplex 2      
Locus 




Concentration, µM Reference 
TH01 F 6'FAM CCTGTTCCTCCCTTATTTCCC 0.5 Butler et al., 2003 
 R  ATTTACAGGGAACACAGACTCCATG 0.5 Butler et al., 2003 
D19S433 F 6'FAM CCTGGGCAACAGAATAAGAT 2 This study 
 R  ATTATTATTCCCGAATAAAAATCTTCTCTCTTTC 2 This study 
D13S317 F 6'FAM GGCAGCCCAAAAAGACAGA 2.5 Krenke et al., 2002 
 R  ATTACAGAAGTCTGGGATGTGGAGGA 2.5 Krenke et al., 2002 
D3S1358 F VIC CAGAGCAAGACCCTGTCTCAT 1 Butler et al., 2003 
 R  ATTTCAACAGAGGCTTGCATGTAT 1 Butler et al., 2003 
D2S1776 F VIC TGAACACAGATGTTAAGTGTGTATATG 4 Hill et al., 2008 
 R  ATTATTATTTCTGAGGTGGACAGTTATGAAA 4 Hill et al., 2008 
D5S818 F NED GGGTGATTTTCCTCTTTGGT 2 Butler et al., 2003 
 R  ATTAACATTTGTATCTTTATCTGTATCCTTATTTAT 2 Butler et al., 2003 
vWA F NED GGACAGATGATAAATACATAGGATGGATGG 1 Krenke et al., 2002 
 R  ATTAGAGGATCCAAGTTGACTTGGCTG 1 This study 
D8S1179 F PET TTTGTATTTCATGTGTACATTCGTATC 1.5 Butler et al., 2003 
 R  ATTACCTATCCTGTAGATTATTTTCACTGTG 1.5 Butler et al., 2003 
DYS390 F PET CTGCATTTTGGTACCCCATA 4 Park et al., 2007 




Table 2. Primer sequences and assay concentration used in Miniplex 2. 
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Size Standard (Applied Biosystems, Foster City, CA). The reverse primers (AIT Biotech, 
Singapore) were unlabeled, with some having an additional ATT or ATTT sequence or a 
concatamer of 2 to 3 ATT blocks added to the 5’ end to promote full adenylation (Krenke et al. 
2002) (Table 1 and Table 2). The use of the concatamer sequence was to create sufficient non-
overlapping spacing in between loci of the miniplex. The final target concentration of the 
forward and reverse was empirically adjusted to generate balanced PCR products as measured 
with the Applied Biosytems (ABI) PRISM® 3100 and is shown in Table 1 (Miniplex 1) and 
Table 2 (Miniplex 2).  
 
1.2 Sample source and extraction protocols 
A set of 251 blood samples stained on FTA card with self-identified ethnicities, including 
83 Chinese, 78 Malays, 90 Indians obtained from annoymous donors were used in population 
concordance studies.  Whole blood samples from 11 annoymous donors were used in this study. 
They were extracted for DNA using phenol/choroform (Maniatis et al. 1982), which is also 
known as the organic extraction method. The DNA extract was further purified and concentrated 
and purified using Mircrocon® YM-100 filters (Millipore Coporation, Bedford, MA). The DNA 
was quantified using the Quantifiler® Human DNA Quantitiation Kit (Applied Biosystems) and 
diluted to concentration of 500pg/µl. For the validation studies, genomic 9948 DNA (Promega 
Corporation, Madison, WI) were used when unspecified. Genomic DNA from male donor 





1.3  PCR Reaction Components and Thermal Cycling Parameters 
  To determine the suitable range of conditions, several amplification parameters were used. 
They included Taq enzyme concentration, annealing temperature, reaction volume and cycle 
number.  1 to 5 U of OmniTaq (DNA Polymerase Technology, Inc, St Louis, MO) in 15µl of 
PCR volume were tested with 500pg of DNA template for Miniplex 1 and Miniplex 2, 
respectively. Annealing temperatures of 55, 57, 58, 59 and 60oC and extension temperatures 
of 65, 68, 70, 72, 74 and 76 oC were tested on Miniplex 1 to establish the optimum 
temperature for PCR. Reaction volumes of 5, 10, 15, 20, 25, 50 µl were tested with 500 pg of 
DNA. The 500pg of DNA template were amplified at 28, 30 and 32 PCR cycles. The testing 
was done in triplicates. In order to promote adenlylation and increase the yield of PCR 
products of Miniplex 2, a series of NaOH concentrations from 0.013, 0.020, 0.026, 0.033 to 
0.040 M were added during PCR. The final PCR reaction components that were used are as 
follows: 1X Primer Mix, 200µM of each dNTP, 1X EzWayTM Direct PCR Buffer 
(Komabiotech, Seoul, Korea) and 1U/15µl OmniTaq (DNA Polymerase Technology, St 
Louis, MO). For Miniplex 2, 0.026M of NaOH was included in the PCR reaction. Thermal 
cycling parameters used were 96oC/2min, followed by 94oC/1min, 59oC/2min, 74oC/1min, 
for 10 cycles, 90oC/1min, 59oC/2min, 74oC/1min for 20 cycles and 60oC/90min. 
 
1.4. Removal of residual dyes after PCR 
   In order to remove residual dye molecules that resulted in “dye blobs” during capillary 
electrophoresis electropherograms and to increase capillary electrophoresis signal levels, 
MinElute spin columns (Qiagen, Inc. Valencia, CA) or MinElute 96 UF PCR Purification kit 
(Qiagen, Inc. Valencia, CA) were used to “clean-up” the PCR products before genotyping on 
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the ABI PRISM® 3100.  A total of 15 µl of the PCR products were processed according to 
the manufacturer’s protocol and the PCR products were eluted in 15µl of EB buffer. 
Whenever the amplification was performed on 0.2ml PCR tubes, MinElute spin columns 
were used, and when PCR was performed on 96-well PCR plates, MinElute 96 UF PCR 
plates were used instead. 
 
1.5 Analysis on the ABI PRISM® 3100  Genetic Analyzer 
  Amplification products were diluted in Hi-Di formamide (Applied Biosystems) by adding 1 
µl PCR product and 0.3 µl GS500-LIZ internal size standard (Applied Biosystems) to 8.7 µl 
of Hi-Di. The samples were analysed on the 16-capillary ABI Prism 3l00 Genetic Analyzer 
after denaturation of samples at 95oC for 3 min and snap-cooled at -20oC for 3min. Prior to 
testing, a 5-dye matrix was established under the ‘‘G5 filter’’ with the five dyes of 6FAM, 
VICTM, NEDTM, PETTM, and LIZTM. Samples were injected electrokinetically for 10 sec at 3 
kV. The STR alleles were then separated at 15 kV at a run temperature of 60oC using the 
POP-4TM (Applied Biosystems) and 1X Genetic Analyser Buffer with EDTA and on a 36 cm 
array (Applied Biosystems). Data from the ABI PRISM® 3100 were analysed using 
GeneScan® Software 3.7 (Applied Biosystems) with peak amplitude threshold set at 50 
relative fluorescence units (RFU) for all colors. Genotypes were generated using Genotyper® 
v3.7 (Applied Biosystems).  
 
1.6 Generation of Allelic Ladder and Genotyper Macros 
   Allelic ladders for the autosomal STRs in Identifiler™ (Applied Biosystems) and Y-STRs 
were created using a 1:1000 dilution of allelic ladders from the Identifiler™ or Yfiler™ 
(Applied Biosystems), respectively.  For each STR locus, 2 µl of the diluted ladders were 
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amplified using 1X GoldST*R buffer (Promega, Corporation, Madison, WI), 2.5 U of 
AmpliTaq Gold® DNA polymerase (Applied Biosytems) and 1µM of primer for each STR 
locus in reaction volumes of 15 µl at 20 cycles using the thermal cycling parametres as 
described by Butler et al. 2003.  D2S1776 allele ladder was generated using a combination of 
individual samples that represent each allele commonly observed in the population data sets. 
The samples were amplified by pooling 500 pg of DNA from each sample in a single PCR 
for 30 cycles using the same PCR conditions. Similarly for SRY and amelogenin, alleles 
were obtained by amplifying 500pg of 9948 (Promega) for 30 cycles.  1µl of amplified PCR 
products for each marker were analysed on the ABI PRISM® 3100 Genetic Analyser 
(Applied Biosytems) to determine the signal level. Varying amounts of PCR products of each 
marker were mixed to generate a balanced signal level (~200 to 300 RFUs) in the combined 
allelic ladder for Miniplex 1 and Miniplex 2 using the MinElute spin column (Qiagen) and 
eluted using a 50µl volume. Genotyper macros were constructed for Miniplex 1 and 
Miniplex 2 to work with the new allelic ladders. 1µl of the allelelic ladder was used as 
reference for each genotyping analysis.  
 
2 Validation studies for Miniplex 1 and Miniplex 2  
 
2.1 Sensitivity Studies  
In order to assess the performance and interpretation guidlelines of Miniplex 1 and Miniplex 
2, varying amount input DNA template and its impact in generating a DNA profile was 
assessed in PCR amplifications. Triplicate amplifications for Miniplex 1 and five repeated 
amplifications for Miniplex 2 were performed on a dilution series of a genomic sample (1, 
0.5, 0.25, 0.125, 0.0625, 0.03125, 0.15625 ng). The heterozygous peak balance ratio at all six 
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DNA amounts was also calculated. Only samples that were heterozygous for a particular 
locus were included in the calculations. Threshold for detection was set at 25 RFUs for this 
study to obtain more data for the calculation. The peak balance ratio was calculated by 
dividing the peak height of the smaller peak by the peak height of the larger peak. For 
samples with complete dropout of one allele, a zero peak balance ratio was assigned. 
 
2.2 Stutter calculations 
To ensure reliable genotyping, intepretation guidelines to distinguish true alleles from stuter 
artefacts generated during PCR are reuqired. Peak heights of stutters and its allele peaks were 
exported from Genotyper® v3.7 (Applied Biosystems) software into Microsoft® Excel. The 
stutter percent was calculated by taking the peak heights of the stutters and dividing over the 
peak height of its allele peaks and expressed as a percentage. The average and highest stutter 
percentage was noted and used as stutter percentage threshold in determining a true allele 
peak from an artefact stutter.  
 
 2.3 Stability Studies 
  To determine PCR efficiency of Miniplex 1 and Miniplex 2 in the presence of varying 
concentrations of inhibitors, porcine hematin (Sigma Aldrich, St. Louis, MO), a heme-
containing known inhibitor, was added to 500 pg of input DNA and amplified with 50 µM 
increments in concentrations, from 0 µM to 500 µM and performed in triplicates for both 
Miniplex 1 and Miniplex 2.  Similary, tannic acid (Sigma Aldrich, St. Louis, MO) and humic 
acid (Sigma Aldrich, St. Louis, MO), which are known inhibitors from leather and soil, 
respecitively were aded in 50 µM increments in concentrations, from 0 µM to 300 µM to 500 
pg of input DNA prior to amplification.   
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2.4 Species Specificity 
 
  To determine that Miniplex 1 and Miniplex 2 demonstrate spcificity for human DNA, a 
variety of animal and microbe DNA were examined. Primate DNA samples with known 
quantity were obtained from Dr. Rolf Meier (Department of Biological Sciences, NUS, 
Singapore) and various non-primate and primate blood samples were obtained from the 
Forensic Chemistry and Phyiscs Laboratory (FCPL), HSA, Singapore. The animal blood 
samples were stained on FTA cards. Microbial DNA that had been quantified was obtained 
from Dr. Sanjay Swarup and Dr. Lim Tit Meng (Department of Biological Sciences, NUS, 
Singapore) and extracts of microbes from decomposing material were directly amplified. 
10ng of liquid DNA template or 1.2mm FTA punch were used for PCR amplification.  
 
2.5 Mixture Studies 
Two male genomic samples were mixed with the total DNA input fixed at 500pg for 
amplification and represented in proportions as follows: 19:1, 9:1, 3:1, 1:1, 1:3, 1:9, and 
1:19. Amplifications for both Miniplex 1 and Miniplex 2 were performed in triplicates. This 
was to establish the sensitivity level of Miniplex 1 and Miniplex 2 by which a minor DNA 
contributor could be detected. 
 
2.6 Degraded DNA Studies 
   To evaluate the efficency of amplification in the presence of degraded DNA, 
dexoyribonulease or Dnase I (New England Biolabs, Ipswich, MA) was used to digest DNA 
for 0, 2, 5, 10, 15 and 20min. 2ng of DNA from each timepoint were added for amplification 
using Miniplex 1 and Identifiler™ (Applied Biosystems). The performance of the two 
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multiplex kits was compared to determine the effciency of Miniplex 1 with Identifiler™. 
Samples were amplified using Identifiler™ in using the protocol specified by manufacturer 
for 28 cycles. 
 
2.7 Concordance Studies  
Samples used for genotyping concordance verification were those included in the National 
Institue of Standards and Technology Standard Reference Material® 2391b (NIST, 
Gaithersburg, MD). Sources of DNA also included female 9947A, 9948 male DNA 
(Promega Corporation, Madison, WI) and 007 male DNA (Applied Biosystems), which were 
used for initial testing of protocols and positive controls for PCR.  
For population concordance, a total of 741 blood samples that were stained on FTA card 
with self-identified ethnicities were used. These were made up of 249 Chinese, 244 Malays, 
and 248 Indians from annoymous donors for comparisons with the genotypes generated using 
the commercial DNA typing STR kit Identifiler™ (Applied Biosystems) to the genotypes 
developed from Miniplex 1 and Miniplex 2 primer sets. The genotypes using the Miniplex 1 
and 2 were developed using a different PCR conditions and components from an earlier 
study. PCR was performed using 1X GoldST*R buffer (Promega, Corporation, Madison, 
WI), 2.5 µg BSA (New England Biolabs, Ipswich, MA), 2.5 U of AmpliTaq Gold® DNA 
polymerase (Applied Biosytems) and 1.5 µl of either Miniplex 1 or Miniplex 2 primer set in 
reaction volumes of 15 µl at 30 cycles using the thermal cycling parametres as described by 
Butler et al. 2003. 
  In order to verify that concordant genotypes were developed with the new DNA 
polymerase and PCR buffer systems but with identical Miniplex 1 and Miniplex 2 primer 
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sets, a subset of 83 Chinese, 78 Malays and 90 Indians samples from the 720 samples were 
genotyped. 
 
2.8 Population Studies 
The STR markers in Miniplex 1 and Miniplex 2 overlapped with the markers used in 
Identifiler™ (Applied Biosystems) and YfilerTM (Applied Biosytems), and the allele 
frequecies of the overlapped markers have been established (Ang et al. 2005, Budowle et al. 
2009, Lim et al. 2005, Syn et al. 2005) and was not compiled for this study. Only the allele 
frequency of the non-overlapping D2S1776 STR marker was analysed using PowerStats v12 
spreadsheet (http://www.promega.com/geneticidtools/powerststs/). 
 
2.9 Casework Studies 
  Quantified DNA extracts using organic extraction method from the laboratory internal 
validation studies on the Maxwell® 16 system (Lim et al. 2009) in comparison to 
phenol/chloroform DNA extraction technique was obtained. Liquid blood from 5 
anoynomous donors stained on a variety of substrate to mock as casework samples. The 
DNA was extracted using organic extraction and purified using Mircrocon® YM-100 filters 
(Millipore Coporation, Bedford, MA). The following substrates were used, white cotton, blue 
denim, leather belt and soil. A total of 9 cigarette butts from anoynomous donors were 
obtained and DNA was isolated using organic extraction. Serial dilutions of the 5 blood 
samples ranging from neat to 1:500 dilutions were also prepared and the DNA was then 
extracted and quantified.  
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  Quantitated DNA extracts using organic extraction from four different completed external 
proficiency test samples comprising of 16 samples were obtained. DNA extracts from 9 
blood sample references left from adjudicated casework samples and DNA extracts from 3 
completed casework samples were used.  To evaluate the performance of Miniplex 1 and 
Miniplex 2, the DNA profiles that had been obtained using Identifiler™ (Applied 
Biosystems) were then compared.  
 
3 Initial development of Miniplex C  
3.1 Design strategy and protocol for Miniplex C 
In order to co-amplify Miniplex 1 and Miniplex 2 primer sets together in one single PCR, 
instead of 2 separate amplifications, a novel strategy was explored. An internal Thymine (T) 
nucleotide was selected and subsituted with Uracil (U) nucleotide in the dye-labelled forward 
primers in Miniplex 1. Similarly, an internal T nucleotide was substituted with Inosine (I) 
nucleotide in the dye-labelled forward primers in Miniplex 2. For D13S317, as no T 
nucleotide was present in the primer sequence, an ATTI sequence was attached to the 5’ end 
of the primer. The positions of the U and I nucleotides subsituition are shown in Table 3 and 
highlighted in bold. As VICTM, NEDTM and PETTM are propreitry dyes of ABI and the 
required U and I nucleotide modifications was not performed by ABI, alternate dyes with 
similar emission characteristics to the ABI dyes were selected (Table 3). As such, Yakima 
Yellow for VIC™, ATTO550 for NED™, ATTO565 for PET™ was selected, with the 
required internal modification of the T nucleotide with etiher U or I nucleotide (EuroGentec, 
Seraing, Belgium).  Primer concentrations were identical to the concenrations used in 
Miniplex 1 and Miniplex 2. PCR components and thermal cycling parameters are identical to 
26 
Miniplex 1 and Miniplex 2 with the only adjustment made by adding both Minplex 1 and 
Miniplex 2, using 1.5 µl each into one PCR of 15 µl volume. 
After PCR, the PCR products were “clean-up” using the MinElute spin column (Qiagen) and 
eluted using a 15µl volume with EB buffer. 5µl of PCR products were aliquoted into two 
0.2ml PCR tubes. To one PCR tube, 0.5 U of Uracil-Specific Excising Reagent (USERTM , 
New England Biolabs, Ipswich, MA) was added and incubated for 37oC for 30 min. To the 
second PCR tube, 2.5 U of Endonuclease V, an inosine cleaving enzyme from Thermatoga 
maritima with 1X reaction buffer (Fermantas, Inc., Hanover, MD) was incubated at 65oC for 
15 min. The processed samples were then genotyped on the ABI PRISM® 3100 using the 
same conditions as described earlier. Alleles were manually assigned by comparing to known 




















Locus Forward Dye Label Primer Seq (5' to 3') 
SRY 6-FAM GTATCGACCUCGTCGGAAG 
Amelogenin 6-FAM CCTTTGAAGTGGUACCAGAGCA 
U D2S1338 6-FAM TGGAAACAGAAAUGGCTTGG 
U D21S11 6-FAM ATTCCCCAAGUGAATTGC 
DYS392  6-FAM ACCTACCAAUCCCATTCCTT 
CSF1PO Yakima Yellow ACAGTAACTGCCUTCATAGATAG  
D7S820 Yakima Yellow GAACACTTGTCAUAGTTTAGAACGAAC 
D13S317  Yakima Yellow ATTUGGCAGCCCAAAAAGACAGA 
TPOX Dragonfly Orange CTTAGGGAACCCUCACTGAATG 
D18S51 Dragonfly Orange TGAGTGACAAAUTGAGACCTT 
D16S539 ATTO 565 ATACAGACAGACAGACAGGUG 
FGA  ATTO 565 AAATAAAATTAGGCAUATTTACAAGC 
TH01 6' FAM CCTGTTCCICCCTTATTTCCC 
D19S433 6' FAM CCTGGGCAACAGAAIAAGAT 
D13S317 6' FAM ATTIGGCAGCCCAAAAAGACAGA 
D3S1358 Yakima Yellow CAGAGCAAGACCCIGTCTCAT 
D2S1776 Yakima Yellow TGAACACAGAIGTTAAGTGTGTATATG 
D5S818 F Dragonfly Orange GGGTGATTTTCCICTTTGGT 
VWA Dragonfly Orange GGACAGATGATAAAIACATAGGATGGATGG 
D8S1179 F ATTO 565 TTTGTATTTCATGIGTACATTCGTATC 







Table 3. Primer sequences and assay concentration used in Miniplex C, which uses both sets of primers 
from Miniplex 1 and Miniplex 2 with an internal T nucleotide being subsituted with U nucleotide 
(Miniplex 1) and T nucleotide (Miniplex 2) and are bolded. The reverse unlabelled primers remain 


















1. Primer Set Optimization 
  In determining the optimal primer concentration, several criteria were taken into 
consideration. Performance criteria, which included overall peak heights, intercolor, 
intralocus and intracolour balance were targeted on 500pg of genomic DNA. The purpose of 
the criteria was to enhance the ability of the multiplex assay to generate full DNA profiles 
from inhibited, degraded or low-levels of DNA samples. A series of primer concentration 
sets were tested to determine the best primer concentration. Based on the results of each test, 
the primer concentrations were adjusted in order to achieve the optimum performance. Figure 
3 and Figure 4 depicts a representative, 500 pg amplification using Miniplex 1 and 2, 
respectively. The best overall peak balance was observed at the primer concentration as 
described in Table 1 and Table 2.  
 In designing the multiplex assay, miniSTR primers were selected as these primers produced 
smaller PCR amplicons and their effectiveness in amplification of degraded DNA was well-
studied (Chung et al. 2004). The exceptions were vWA and D13S317 where published 
primer sequences from the commercial kit Powerplex 16 (Promega) were selected for both 
Miniplex assays. The reason for their selection instead of miniSTR primers were due to 
several discordant alleles found in both vWA and D13S317 (Drábek et al. 2004 and Hill et 
al. 2007). In addition, for vWA, the miniSTR amplicon size ranges from 88 to 148 bp (Butler 
et al. 2003) and the Powerplex 16 vWA primers generate amplocons from 123 to 171 bp 
(Krenke et al. 2002) and both primer sets overlaps with D5S818 in Miniplex 2, whose size 
range is from 106 to 143 bp. Therefore, only the forward Powerplex 16 vWA primer 
sequence was used while the reverse primer for vWA was re-designed to generate larger PCR 











































































D13S317 primers also ensure the amplicons did not overlap with the other STR loci. 
D13S317 also served as a common STR marker, being present in both Miniplex 1 and 2. This 
allowed cross-reference of the DNA profiles generated by the two Miniplex assays and 
served as a check in detecting sample mix-up. D2S1776 was included in Miniplex 2 as a non-
CODIS STR locus and is one of 26 new STR markers that has been recently characterized 
and recommended for use in severely degraded DNA (Hill et al. 2008).  These new markers 
were selected as they are unlinked from existing markers from the 13 CODIS loci or at least 
50 Mb apart from existing locus used and produced short PCR products in the target region 
of 50 to 150 bp as these primer sequences were placed directly next to the repeat region 
unlike some of the CODIS markers. CODIS STRs such as FGA and D7S820 contain partial 
repeat or monoucleotide repeat stretches that prevent the primers to be designed close to the 
core repeat region (Butler et al. 2002) thus amplicons will need to be larger as the primers are 
required to be placed away from the repeat stretches. As a result, D2S1776 from the 26 novel 
MiniSTR markers were selected to be included in our miniplex assays. Our laboratory had 
recently developed a new multiplex assay, consisting of 8 of these new markers, together 
with vWA (Lim, unpublished data) to cross-reference with Miniplex 2. Having D2S1776 in 
Miniplex 2 and the rest 8 MiniSTR markers will allow the laboratory to increase the number 
of STR markers suitable to genotype degraded DNA samples.  
 
2. PCR Reaction Components and Thermal Cycling Parameters 
   One of the driving reasons of developing Miniplex 1 and 2 was to overcome PCR 
inhibition. PCR polymerases such as Phusion Polymerase (Finnzymes, Woburn, MA), 
OmniTaq and OmniKlentaq (DNA Polymerase Technology); and known PCR enhancers 
such as Betaine (Sigma Aldrich, St. Louis, MO) and BSA, varying MgCl2 and EDTA 
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concentrations, PCR additives PEC-1 and PEC-2 (DNA Polymerase Technology) and PCR 
buffer systems, Gold ST*R buffer (Promega), STRboost® (Biomatric, Inc., San Diego, CA), 
Rockstart buffer (DNA Polymerase Technology) and EzWayTM Direct PCR Buffer 
(KomaBiotech, Seoul, Korea) were evaluated either independently or in combinations with 
one another in a single PCR reaction. These PCR reactions were challenged by increasing 
concentration of hematin from 0 µM to 150 µM and using 500pg of genomic DNA for 
amplification and using 30 PCR cycles using Miniplex 1. A summary of this evaluation study 
is given in Table 4. EzWayTM PCR buffer with OmniTaq had the highest potential in 
overcoming PCR inhibition. OmniKlentaq was dropped from further evaluation as several 
non-specific PCR artifacts were observed. In contrast OmniTaq had two distinct non-specific 
PCR artifacts, approximately 191 and 195 bp in size at the FGA locus. Optimising the PCR 
annealing and extension temperature in Miniplex 1 can overcome PCR artifacts by increasing 
the specificity of PCR amplification.  
  EzWayTM buffer had been used for direct PCR amplification from forensic samples (blood, 
salvia, sperm, etc.) without any DNA purification step (Park et al. 2005, Barbaro et al. 2006, 
Barbaro et al. 2008). In Table 4, the buffer when used with AmpliTaqTM Gold (Applied 
Bioystems, Foster City, CA), could overcome 90 μM of hematin. OmniTaq or Taq22 is a Taq 
DNA polymerase mutant at codon 708 and had been demonstrated to confer enhanced 
resistance to various inhibitors of PCR (Kermekchiev et al. 2009).  Hence from the 
evaluation study, the combination of EzWayTM buffer and OmniTaq abilities to overcome 





  Tested components or combinations for 
PCR 
Concentration of hematin 
when partial DNA profile 
are observed, Test Range 
(0 to 150μM) 
Remarks 
2.5mg of BSA 40μM   
1xPromega ST*R Buffer 40μM   
Addition of Betaine 40μM   
Addition of BSA (2.5mg) with Betaine 
(0.5M) 40μM   
Phusion Polymerase -  Amplification failure 
3mM of MgCl2 60μM   
4.5mM of MgCl2 50μM   
3μM of MgCl2 with 2.5mg of BSA 60μM   
4.5μM of MgCl2 with 2.5mg of BSA 90μM   
Phusion Polymerase, 3mM MgCl2 - Amplification failure 
Phusion Polymerase, 4.5mM MgCl2  - Amplification failure 
1x EzWay buffer  90μM   
1xEzway buffer, BSA (2.5mg) with 4.5mM 
MgCl2 20μM   
4.5μM MgCl2 with 2.5mg of BSA 90μM   
Biomatric STRboost 60μM   
OmniKlentaq - Non specific amplification products 
OmniKlentaq, with 2.5mM EDTA - Non specific amplification products 
OmniKlentaq with PEC 1 - Non specific amplification products 
OmniKlentaq, PEC 1 with 2.5mM EDTA - Non specific amplification products 
OmniKlentaq with Ezway buffer >150μM Non specific amplification products 
OmniKlentaq with 1x Gold ST*R Buffer - Amplification failure 
OmniKlentaq with PEC2 10μM Non specific products 
OmniKlentaq, 1x Gold ST*R buffer with 
2.5mg BSA - Amplification failure 
1xEzway buffer with 2.5mg BSA 30μM   
OmniKlentaq with Rockstart buffer - Amplification failure 
OmniTaq 0μM Partial DNA profile 
OmniTaq with ST*R buffer 0μM 
incomplete adenlylated PCR products, 
imbalanced intralocus and interlocus 
amplification 
OmniTaq with EzWay 
>150μM 
Non-specific amplification products at 
PCR product at FGA marker 
Table 4. List of tested components for PCR. 1U AmpliTaq Gold (Applied Biosystems) was used 
when the PCR polymerase is not stated.  
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buffer and enzyme were designed to overcome PCR inhibition. The combination enhanced 
tolerance to PCR inhibitors to those reported for independent studies of either buffer or 
enzyme assays. 
  A series of annealing temperatures, which included 55, 57, 58, 59 and 60oC were tested on 
Miniplex 1 using 500 pg of 007 (Applied Biosystems, Foster City, CA), 9947A (Applied 
Biosystems, Foster City, CA) and 9948 (Promega Coporation, Madison, WI) control DNA 
samples. The annealing time for PCR used was 2 minutes instead of 1 minute, even though 
the amplicons size was under 250 bp. This was done to promote efficiency of primer to DNA 
template annealing, resulting in more successful DNA polymerization when inhibitory PCR 
conditions associated typically with forensic samples are encountered. It has been observed 
that the yield of PCR increased when the annealing time was increased (data not shown).  For 
the annealing temperature tests, PCR artifacts were detected for all annealing temperatures, 
however at 59 and 60 oC, the artifacts were below detection levels of 100 RFUs. Generally at 
increasing annealing temperature, PCR artifacts were reduced at the FGA locus (Fig. 5). 60 
oC were dropped due to allele drop-outs observed at D21S11 and FGA loci. Given the desire 
to minimise PCR artifacts, maximal specificity and with annealing temperature of 59 oC 
having robust PCR amplification with peak heights being balanced, this temperature was 
determined to be the best annealing temperature for PCR. 
  A series of extension temperature, which included 63, 67, 70, 72, 74 and 76oC were tested 
on Miniplex 1. In general, PCR artifacts decreased and PCR products increased with 
increasing extension temperatures with the exception at 76 oC, where the PCR products 

































Figure 5. Representative example of the effect of variation in annealing temperature for Miniplex 1 at the 
FGA locus. Increasing annealing temperature (as indicated in each panel) shows a general decrease of 
































Figure 6. Representative example of the effect of variation in extension temperature for Miniplex 1 at the FGA 
locus. Increasing extension temperature (as indicated in each panel) shows a general increase of PCR 
amplicons except at 76oC. PCR artifacts at 191 and 195 bp are marked by the pointed arrows also show a 
general decrease with increasing extension temperature. 
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increased specificity of amplification. Complete DNA profile is obtained for the tested 
annealing temperatures from 55 to 59 oC, while at 60 oC, severe interlocus peak imbalance 
yield is highest and the artifacts were reduced to a minimal. Taken together with annealing of 
OmniTaq was not optimal, resulting in a decreased PCR product yield. At 74 oC, PCR 
increased specificity of amplification. Complete DNA profile was obtained for the tested 
annealing temperatures from 55 to 59 oC, while at 60 oC, severe interlocus peak imbalance 
yield was highest and the artifacts were reduced to a minimal. Taken together with annealing 
test, it was determined that the PCR annealing and extension temperature would be fixed at 
59 oC and 74 oC, respectively. Incremental concentration of MgCl2 i.e. by adding 2 mM, 2.5 
mM and 3.5 mM of MgCl2 in the PCR reaction for Miniplex 1 were studied and this resulted 
in the 191 bp being more pronounced (data not shown) with increasing concentration of 
MgCl2. 
  When testing for the PCR components and conditions for Miniplex 2, inefficient 
amplification and incomplete adenlylation was encountered resulting in split peak 
morphologies in TH01, D3S3158, D2S1776, D5S818, vWA and D8S1179, which was 
severely pronounced in D5S818 and vWA (Fig. 7). Wang et al. (2008) reported split-peak 
morphologies in several STR markers in a multiplex assay that was challenged with low pH 
using acetic acid and increasing the final PCR final extension time to 90 minutes can 
complete the “+A” addition. In view of this, a final PCR extension time of up to 180 minutes 
was attempted on Miniplex 2 without any improvement (data not shown). As the split peak 
morphology had been attributed to low pH (Wang et al. 2008), NaOH of varying 
concentrations are added to the PCR reaction mix on Miniplex 2. This was to determine 
whether an increase in pH in the PCR reaction could circumvent the incomplete adenlylation 
and increased the efficiency of PCR amplification. The outcome of the NaOH testing is 
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shown in Fig. 7. Complete adenlylation of all the STR markers were observed even at the 
lowest concentration of NaOH of 20 mM. However, at concentrations of 60 mM and above, 
PCR inhibition was observed, likely a result of the pH being too high for OmniTaq 
polymerase to function.  
 To determine whether the amplification conditions for Miniplex 1 was amendable to 
Miniplex 2, a series of annealing temperatures were tested on Miniplex 2, with other PCR 
parameters remaining unchanged. The outcome of the testing is shown in Fig. 8.   PCR 
annealing temperature of 58 oC has the highest and most balanced DNA profile. However an 
annealing temperature of 59 oC was chosen instead as the PCR product yield was higher and 
the conditions would also be identical to that of Miniplex 1, allowing the same PCR protocol 
to be used for both multiplex assays. Two PCR artifacts at D2S1776 locus were detected at 
all tested annealing temperatures and are 167 and 171 bp in size. The positions of the PCR 
artifacts are off the allele positions of known alleles of D2S1776 and would be easily 
identifiable as PCR artifacts (Fig 8). 
  For the Taq polymerase study, 1U of enzyme was sufficient to amplify 500 pg of DNA at 
30 cycles. Higher concentration of enzyme resulted in either over-amplification resulting in 
PCR artifacts formation or severe inter-locus peak imbalance (Fig. 9). As a result, enzyme 
concentration of 1U was used for both Miniplex 1 and 2.   
  Magnesium concentrations were not tested on Miniplex 2. The PCR buffer, EzWay 
(KomaBiotech) is a pre-formulated PCR buffer with MgCl2 added and has been optimised 
for PCR amplification (Park et al. 2005, Barbaro et al. 2008). No further MgCl2 testing was 
performed and increasing concentration could cause non-specific binding resulting in“allele 








Figure 7. NaOH titration on Miniplex 2. Concentration of NaOH is shown in each panel. In the absence of NaOH, split-peak morphology is 
observed due to incomplete adenlylation. In the presence of NaOH, complete adenlylation is observed. At 27 mM of NaOH, a balanced and 








Figure 8. Representative example of the effect of variation in annealing temperature for Miniplex 2 at the 
FGA locus. Increasing annealing temperature (as indicated in each panel) shows a general increase of PCR 
amplicons. PCR artifacts at 167 and 171 bp are marked by the pointed arrow which is consistently detectable 



















Figure 9. Miniplex 1 (left) and Miniplex 2 (right) titration of OmniTaq DNA polymerase. 500pg/15 µl of DNA template was amplified at 30 cycles 




























28 cycles 28 cycles 
30 cycles 
32 cycles 32 cycles 
30 cycles 
Figure 10. Cycle number study for Miniplex 1. On left, amplifications of 250pg/15μl of DNA at different cycle numbers as indicated in each 












Figure 11. Cycle number study for Miniplex 2. Amplifications were performed using 500pg/15μl of DNA at different cycle numbers 
as indicated in each panel. 28 and 30 cycles give amplification within the detection limts of ABI 3100 while for 32 cycles, over-



























Figure 12. Minplex 1 reaction volume study using 30 PCR cycles and 500 pg of DNA with varying 
PCR volumes (as shown in each panel). Complete DNA profiles were obtained at all PCR volumes 



































Figure 13. Minplex 2 reaction volume study using 30 PCR cycles and 500 pg of DNA with varying PCR 
volumes (as shown in each panel). Complete DNA profiles were obtained at all PCR volumes that are 
studied. R60 male genomic DNA was used in this study. 
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PCR cycle number studies for Miniplex 1 were conducted using 250pg and 500pg of DNA 
template over 28, 30 and 32 cycles. For Miniplex 2, 500pg of DNA template over 28, 30 and 
32 cycles were tested. Good peak balance was observed for all PCR cycle number and 
successful amplification was obtained for each of the tested cycles, using Minplex 1 (Fig. 10) 
and Miniplex 2 (Fig. 11). Overall, increasing the cycle number enhanced the PCR product 
yield, however lower cycle number could achieve better peak balance. Using 30 cycles for 
amplifying DNA samples with 500pg is recommended as it achieves the best balance it terms 
of sensitivity and profile quality.     
  Reaction volumes of 5-50 μl provided good amplification results for both miniplex assays 
and produced consistent DNA profiles. It was interesting to note that with Miniplex 1, 
increasing volumes of PCR reaction resulted in a decrease in signal intensity, a consequent of 
decreasing amplicons while Miniplex 2, the reverse was true. The result of Miniplex 1 was 
not surprising, given that the DNA template was being kept constant at 500 pg. Therefore, 
increasing PCR volume will reduce the sensitivity of amplification process. The difference 
between the 2 miniplex 2 assays might be due to the addition of NaOH in Miniplex 2, which 
acted as a PCR enhancer. While the PCR volume has no detrimental effect, to minimize 
pipetting errors due to small volumes (Cotton et al. 2000), the 15 μl PCR volume is chosen. 
  MiniElute (Qiagen, Inc. Valencia, CA) columns were also used for “PCR clean-up” after 
amplification. Firstly, to remove ‘dye-blobs’, an artefact that is due to unattached primer dye 
labels that co-migrates with the amplicons during genotyping (Butler et al. 2003). Secondly, 
to increase the detection sensitivity of the amplicons during genotyping which has been 
reported to result in 3 to 8-fold increase in signal intensity (Smith and Ballantyne 2007).  
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3. Sensitivity, Peak Balance and Stutter 
  In the sensitivity study, amplification for all loci was obtained for template concentrations 
as low as 16 pg for Miniplex 1 (n=3) and Miniplex 2 (n=5). Correct genotypes were obtained 
at concentrations as low as 32 pg for the majority of the samples tested with Miniplex 1 and 
2. Allele dropouts started to occur at 125 pg though with longer injection time of 3kv 10s to 
3kv 20s would recover the dropout alleles (data not shown). The overall results of the study 
are presented in Table 5. Correct genotypes were detected at as low as 16 pg, but starting 
from 125pg, allele dropouts began to occur though limited to the D21S11 in Miniplex 1 and 
DYS390 in Miniplex 2, gradually affecting other markers as template concentration 
decreased. Stochiastic amplification resulted when low levels (<100pg) of DNA are used, 
which can results in either severe allele imbalances or allele droputs. This was observed for 
DNA tempate concentration of 31 pg and below for both miniplex assays. This was evident 
by the wide error margins shown in both Fig. 15 and Fig. 17.  At 16pg, 16 out of 18 alleles 
were successfully amplified using Miniplex 1 and for Miniplex 2 14 out of 15 alleles were 
observed, indicating the high sensitivity of both miniplex assays.  Based on these data, 
template input of 250-500 pg was optimal for Miniplex 1 (Fig. 14) and Miniplex 2 (Fig 16). 
At this template range, Miniplex 1 and Miniplex 2 was able to achieve intra-locus peak 
balance higher than 50%, and the average peak heights of 2500 and 1800 RFUs, respectively, 
which is above our laboratory detection threshold of 100 RFU set for our ABI 3100. 
  Stutter is a biological artefact, which occurs during PCR due to slippage of the DNA 
polymerase enzyme (Klintschar and Wiegand, 2003 and Gibb et al. 2009) which results in a 
peak, one repeat unit shorter than the true allele at a much reduced level. Sttuer percentage is  
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Average Peak Balance 
(%) 
Miniplex 1 (n=3) 1000 100 4103 88 
 500 100 3284 78 
 250 100 1675 76 
 125 67 1201 75 
 63 33 791 59 
 31 0 344 43 
 16 0 192 45 
Miniplex 2 (n=5) 1000 100 2834 81 
 500 100 2274 81 
 250 100 1233 82 
 125 80 635 71 
 63 60 319 39 
 31 40 149 21 





Template concentrations, percentage of full amplification (detection of all alleles in all loci), 
average RFU for all loci, and average peak balance for all loci are shown. Miniplex 2 was amplified 







Figure 14. Sensitivity studies for Miniplex 1. The change in fluorescence signal intensity as a function of template 
concentration is shown. All samples were amplified at 30 cycles. No allele dropout and good signal intensities (> 2500 RFU) 
were achieved at template concentrations >250 pg ⁄ 15µl. Error bars represent +95% confidence interval from the average 
peak intensity. Blue panel represents the loci labelled with 6’FAM, SRY, Amelogenin, D2S1338, D21S11, DYS392. Green 
panel represents the loci labelled with VIC, CSF1PO, D7S820 and D13S317. Yellow panel represents the loci labelled with 





Figure 15. Peak balance ratio for Miniplex 1. The average peak balance ratio for  Miniplex 1 is plotted as a function of 
template concentration. All samples were amplified at 30 cycles. Template concentrations >125 pg ⁄ 15 µl  gave good peak 






Figure 16. Sensitivity studies for Miniplex 2. The change in fluorescence signal intensity as a function of template 
concentration is shown. All samples were amplified at 30 cycles. No allele dropout and good signal intensities (> 1500 RFU) 
were achieved at template concentrations >250 pg ⁄ 15µl. Error bars represent +95% confidence interval from the average 
peak intensity. Blue panel represents the loci labelled with 6’FAM, TH01, D19S433 and D13S1317. Green panel represents 
the loci labelled with VIC, D3S1358 and D2S1775. Yellow panel represents the loci labelled with NED, D5S818 and vWA. 
Red panel represents the loci labelled with PET,  D8S1176 and DYS390. 
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 Figure 17. Peak balance ratio for Miniplex 2. The average peak balance ratio for  Miniplex 1 is plotted as a function of 
template concentration. All samples were amplified at 30 cycles. Template concentrations >500 pg ⁄ 15 µl  gave good peak 



























































































Figure 18. Average stutter calculated for each locus of the Miniplex 1. The sample size (n) indicates the number of samples 
used to calculate stutter for each locus. Error bars represent +95% confidence interval from the average stutter value. The 




























































































Figure 19. Average stutter calculated for each locus of the Miniplex 2. The sample size (n) indicates the number of samples 
used to calculate stutter for each locus. Error bars represent +95% confidence interval from the average stutter value. . The 











calculated from the ratio of the stutter peak height to that of the true allele. Stutter percentage 
was less than 17% of all alleles observed except for D21S11, where the highest observed 
stutter was 26.6%. D2S1776 and TPOX loci were found to have the lowest stutter precentage 
through its whole panel of alleles (Fig. 18 and Fig. 19). The highest observed stutter for each 
locus was set as stutter filter threshold as the cut-off level to distinguish true alleles as minor 
alleles for mixture interpretation from that of stutters. Average stutter percentage increased as 
alleles became larger or the STR locus had complex or polymorphic STR repeats such as 
D21S11 and FGA (Frank et al. 2001). The amount of stutter appeared higher than Identifiler® 
and this was likely related to the DNA polymerase processivity, or how rapidly the 
polymerase copied the template strand. Identifiler® uses Amplitaq Gold while both miniplex 
assays uses a Taq mutant for amplification.. Stutter products have been shown to increase 
relative to their corresponding alleles with a slower polymerase (Walsh et al. 1996, 
Meldgaard and Morling 1997), which would mean the processivity of the OmniTaq used for 
both miniplexes have lower processitivity compared to AmpliTaq Gold used in Identifiler®. 
 
4. Stability 
  In order to characterise amplification performance in the presence of either inhibited or 
degraded DNA, stability studies were done, both factors being known to impact PCR 
efficiency (Adams et al. 1991, Akane et al. 1994, De Franchis et al. 1988, McNally et al. 
1989, McNally et al. 1989). To evaluate the effects of inhibition on amplification, porcine 
hematin, tannic acid and humic acid, which are common environmental inhibitors, were 
added in increasing concentrations into PCR. These inhibitors are added unto 500 pg of DNA 
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template prior to PCR in concentrations varying from 0-500 μM for hematin, 0 to 400 ng/μl 
of humic acid and 0 to 300 ng/μl of tannic acid.  
  When challenged with hematin, allele dropouts was first observed with 300 μM of hematin 
with Miniplex 1 and affects the markers D21S11 and FGA at 1 out of the 5 replicates. For 
Miniplex 2, alleles begin to dropout at 400µM of hematin. Interestingly for Miniplex 1, with 
increasing concentration of hematin, the amplifiction appeared to be more robust, evident by 
the increasing RFUs. Even when the concentration of hematin becomes inhibitory for 
amplification, the amplified markers still adhere to the trend of increasing peak heights. This 
effect is less pronounced in Miniplex 2 (Fig. 20 and Table 6). However, for Miniplex 2, it 
was able to withstand higher concentration of hematin than Miniplex 2 (Fig 21 and Table 7). 
This could be due to Miniplex 2 having less markers than Miniplex 1, enabling the efficiency 
of amplification. Another possible reason could be the STR markers found in Miniplex 2 
have simple repeats, compared to  Miniplex 1 which contains hypervariable complex repeats 
such as D21S11 and FGA, which were the first loci that experienced dropouts at increasing 
concentrations of hematin. This effect might be similar to GC-rich DNA template which 
affects template denaturation during amplification (Frey et al. 2008 and Mamedov et al. 
2008).  Both Miniplex 1 and 2 were observed to have increased heterozygote peak 
imbalance, as reflected by the decreasing peak height balance with increasing hematin 
concentrations (Table 6). For Miniplex 2, vWA peak height balance is severely affected, as 
shown in Figure 21. With increasing hematin amounts, it resulted in the smaller allele being 
amplified preferentially over the larger allele by 4 fold.  In commercial kits, locus dropout 
typically proceeded from larger loci to smaller loci as hematin concentration increased 




















Figure 20. Representative results from stability study of hematin on Miniplex 1. Concentration of hematin shown in each 
panel. With increasing concentration of hematin, RFUs correspondingly increases though allele dropouts are observed at 
some loci. Allele dropouts are first observed at 300 μM hematin. However, at 500 μM, 14 out of 19 possible alleles were 













Figure 21. Representative results from stability study of hematin on Miniplex 2. Concentration of hematin shown in each 
panel. With increasing concentration of hematin, overall peak heights decreases. Allele dropouts are first observed at 400 μM 























Average Peak Balance 
(%) 
Miniplex 1 (n=5) 0 100 1129 79.4 
 50 100 2854 80.3 
 100 100 4518 85.7 
 150 100 2625 77.8 
 200 100 4649 86.8 
 250 100 3076 85.7 
 300 80 4160 78.3 
 350 40 2111 66.4 
 400 0 4328 55.9 
 450 0 4160 57.8 
 500 0 2649 36.3 
     
Miniplex 2 (n=5) 0 100 2596 77.3 
 50 100 1172 79.1 
 100 100 1638 80.6 
 150 100 1664 80.2 
 200 100 1598 79.1 
 250 100 1070 80.2 
 300 100 664 78.0 
 350 100 815 79.2 
 400 80 649 66.4 
 450 40 420 28.8 
 500 40 163 30.2 
 Percentage of full amplification (detection of all alleles in all loci), average RFU for all loci, and average 






Figure 22. Representative results from stability study of humic acid on Miniplex 1. Concentration of humic acid was shown 
in each panel. With increasing concentration of humic acid, peak heights of the loci that were amplified remained unchanged 
though allele dropouts occur at higher concentrations of humic acid. Allele dropouts for one locus, D21S11 were first 





















Figure 23. Representative results from stability study of humic acid on Miniplex 2. Concentration of humic acid are shown 
in each panel. With increasing concentration of humic acid, selected loci are increasing intensity in their peak heights while 
the rest remains unaffected. Allele dropouts were first observed at 150 ng/μl humic acid. However, even at 350 ng/μl humic 






















Average Peak Balance 
(%) 
Miniplex 1  0 100 3425 82.3 
 75 100 3302 90.3 
 100 100 2550 84.5 
 150 67 3334 78.9 
 200 100 2195 82.9 
     
Miniplex 2  0 100 611 72.0 
 50 100 1294 73.6 
 100 100 1158 72.2 
 150 100 1725 75.6 
 200 100 466 75.2 
 250 50 297 67.0 
 300 100 369 75.6 
 350 50 415 49.3 
 400 0 98 0 
     
 
. For Miniplex 1, a few loci such as SRY, Amelogenin, D16S539, CSF1PO, D7S820, 





For 0 to 200 ng/µl of humic acid, triplicates for each concentration were tested. For 250 ng/µl to 400 
ng/µl of humic acid, duplicates of each humic acid concentration were tested.  Percentage of full 
amplification (detection of all alleles in all loci), average RFU for all loci, and average peak balance for 
all loci were studied to study the effects of humic acid inhibition on amplification.  
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reduction is observed. For Minplex 1, a few loci such as SRY, Amelogenin, D16S539, 
CSF1PO, D7S820, D13S317 showed preferrential amplifcation while the rest of the loci have 
reduced peak heights 
  For samples that were challenged with humic acid, the observations were similar to 
hematin (Fig. 20, Fig. 21 and Table 6) by which increasing concentrations of humic acid 
resulted in decreased amplification of several loci, especially D21S11 and FGA in Miniplex 
1 while for Miniplex 2, a more balanced decrease across all loci is observed. Kermekchiev 
and co- workers (Kermechiev et al. 2009) reported Taq 22 mutant or OmniTaq, which is the 
DNA polymerase used in the miniplex assays, that humic acid has a stimulatory effect on the 
mutant DNA polymerase. This stimulatory effect was more prononced in Miniplex 2, where 
concentrations of between 50 ng/μl to 150 ng/μl of humic acid enhanced PCR, but  
concentrations above that resulted in PCR inhibition (Fig 21).  This could potentially mean 
that adding 50 ng/μl to 150 ng/μl of humic acid could act as a  novel PCR enhancer specific 
to the mutant OmniTaq polymerase. 
  For samples that were challenged with tannic acid, the results were surprising. Miniplex 1 
was able to withstand inhibition of up to 150 ng/µl of tannic acid, without any of the samples 
showing allele dropouts and full amplification was still observed at 250 ng/µl of tannic acid 
(Fig. 24 and Table 8). For Miniplex 2, the presence of tannic acid caused a reduction in 
amplification efficiency. However, amplification with increasing concentration of tannic acid 
remains consistent (Fig. 25 and Table 8) without any detriment to PCR except when tannic 





















Figure 24. Representative results from stability study of tannic acid on Miniplex 1. Concentration of tannic acid were shown 
in each panel. With increasing concentration of tannic acid, locus dropout proceeded from the largest locus, DY392 before 
rest of the loci were affected.  Allele dropouts were first observed at 200 ng/μl tannic acid. However, even at 250 ng/μl tannic 





















Figure 25. Representative results from stability study of tannic acid on Miniplex 2. Concentration of tannic acid were shown 
in each panel. With increasing concentration of tannic acid, efficiency of amplification remained consistent. Allele dropouts 

















Average Peak Balance 
(%) 
Miniplex 1 (n=3) 0 100 3847 84.6 
 75 100 3461 83.1 
 100 100 2984 79.5 
 150 100 2357 85.1 
 200 33 1311 88.8 
 250 33 1402 80.1 
 300 0 506 74.8 
     
Miniplex 2 (n=3) 0 100 3532 79.0 
 50 100 1390 76.1 
 100 100 634 77.1 
 150 100 483 76.1 
 200 100 480 72.8 
 250 50 350 64.6 
 300 100 483 77.8 
     
  Percentage of full amplification (detection of all alleles in all loci), average RFU for all loci, 
and average peak balance for all loci were studied to study the effects of tannic acid 
inhibition on amplification.  
 





Figure 26. Representative results from degradation study between Miniplex 1 (panels on left) and Identifiler (panels on 
right). Incubation time with DNAse I were shown in each panel. At 20 minute incubation time for both Miniplex 1 and 
Identifiler®, the Y-scale is expanded for both set of results as amplification was compromised. Amplifications for both 
Miniplex 1 and Identifiler® were done in triplicates. R120 male genomic DNA was used in this study. 










 The stability studies using hematin, humic acid and tannic acid demonstrated an extremely 
high inhibitor tolerance of Miniplex 1 and 2, which would be ideal for forensics DNA typing 
analysis challenged with inhibitors. Compared to the Identifiler® multiplex kit, which our 
laboratory currently uses for forensic DNA typing which experiences amplification failure at 
22 μM of hematin (Collins et al. 2004), the tolerance of Miniplex 1 and 2 to hematin is at  
least 15-fold higher than Identifiler®. 
  To demonstrate that the miniplex assay is more resistant to DNA template that is degraded, 
DNA template was subjected to Dnase I digestion for different time intervals. Only Miniplex 
1 was compared to Identifiler® as the STR loci used in Miniplex 1 are the largest 8 STR loci 
found in Identifiler®. This is done to determine the recovery of the larger STR loci found in 
Identifiler® that are affected first when DNA template becomes smaller due to degradation.  
As shown in Figure 26, the results for Miniplex 1 for time intervals 0, 5, and 10 minutes 
demonstrates over-amplification as 2ng of DNA was added to both Miniplex 1 and 
Identifiler®. 1ng of DNA as quantitated before DNA digestion was added for both multiplex 
systems at each time intervals to offset the loss of amplifiable DNA due to DNase I 
digestion. Surprisingly, FGA locus in Miniplex 1 was not detectable at all digestion time 
intervals, possibly inhibited by the high DNA template concentration, present either as 
digested and undigested forms. Full DNA profiles with the exception of FGA is obtained for 
Miniplex 1, while for Identifiler®, full DNA profiles were obtained at 0, 5 and 10 minutes 
time interval, full DNA profiles are obtained. At 15 minute interval, Identifiler® showed 
several losses of detectable alleles and at 20 minute interval, complete loss of detectable 
alleles was observed. The results demonstrated that Miniplex 1 was able to recover the loss 
of alleles that are experienced by Identifiler®, whenever the DNA template was highly 
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degraded which is consistent with studies done by other groups using MiniSTR primers to 
genotyped degraded DNA (Chung et al. 2004, Hummel et al. 1999, Alonso et al. 2001, 
Takahashi et al. 1997, Whitaker et al. 1995, Clayton et al. 1995). 
 
5. Mixture 
  Table 9 and 10 describe the genotyping results for several mixture ratio of two male 
individuals at 10 loci for Miniplex 1 and 9 loci for Miniplex 2. The alleles contained in the 
table were based upon non-overlapping alleles determined from the non-mixed controls. 
Mixture study was conducted in which the total DNA input was maintained at 500 pg, and 
was designed to determine whether the two miniplex assays are able to detect low level 
mixtures, a scenerio which are found in forensic samples. Data from the experiments show 
that the minor component was present consistently at 10% of the total quantity of DNA 
template (50 pg minor contributor) for Miniplex 1. Genotypes from mixtures of 1:20 were 
detectable, but not without exceptions. For two replicates, the minor alleles (at CSF1PO, 
D7S820 and D13S317 locus) were either filtered away as it fell below the stutter threshold of 
the locus or the alleles were not detectable or under the detection threshold set at 50 RFU (at 
D2S1338, D21S11, D18S51, D16S539 and FGA locus). Therefore, when evaluating minor 
component alleles that fell in the stutter position of a major component, minor allele from 
1:20 mixtures could be wrongly filtered as stutters, which indicates 1:20 as the lower limit of 
mixture detection for Miniplex 1. 
  For Miniplex 2, the experiments showed that the minor component were present 
consistently at 25% of the total quantity of DNA template (125 pg minor contributor).  
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Table 9 – Minor component genotype at non-overlapping alleles from replication 
amplification using Miniplex 1 
Mixture 
Ratio 












18,19 29 14 10,13 11 
10:
1 
18,19 29 14 10,13 11 
3:1 18,19 29 14 10,13 11 
1:3 23,24 31 13 12 10 
1:1
0 
23,24 31 13 12 10 
1:2
0 
23,24 31 13 12 10 
1:2
0 
23,24 ND 13 * 10 
1:2
0 
ND ND 13 * * 
Mixture 
Ratio 










8 8 17,18 12 21 
10:
1 
8 8 17,18 12 21 
3:1 8 8 17,18 12 21 
1:3 10 11 13,14 9,10 24 
1:1
0 
10 11 13,14 9,10 24 
1:2
0 
* 11 13,14 9,10 24 
1:2
0 
* 11 13,14 9.10 24 
1:2
0 
* 11 ND ND ND 
 
 *Allele present at stutter position of major component but below stutter filter threshold.  
 N.D:Alleles not detected (<50 RFU).  
 Detected genotype of minor component using a peak amplitude threshold of 50 RFU. Mixture ratio, which is 
displayed once as triplicate results are identical, established by reference sample (data not shown). Mixture ratio 
of 1:1 was also studied in triplicates as controls for complete amplification of all alleles from both reference 




Table 10 – Minor component genotype at non-overlapping alleles from replication 
amplification using Miniplex 2 
Mixtur
e Ratio 


















0 20:1 - ND ND 
 
17 * * ND 11 21 
20:1 - ND ND 17 * * 17 11 21 
20:1 - 14 ND 17 10 * ND 11 21 
10:1 - 14 8 17 10 10,12 17 11 21 
3:1 - 14 8 17 10 10,12 17 11 21 
1:3 10 13 10 - 12 11 16 10 24 
1:10 ND 13 ND - 12 11 * * ND 
1:10 10 * 10 - 12 11 * * 24 
1:10 ND * ND - 12 11 * * 24 
1:20 ND ND ND - ND * ND * ND 
1:20 ND ND ND - ND 11 ND * ND 
1:20 ND * ND - ND * ND * ND 
 
 *:Allele present at stutter position and below stutter filter threshold.  
N.D:Alleles not detected (<50 RFU).  
– Overlapped alleles between the 2 reference samples.  
Detected genotype of minor component using a peak amplitude threshold of 50 RFU. Mixture ratio, which are 
displayed once as triplicate results are identical, established by reference sample (data not shown). Mixture ratio 
of 1:1 was also studied in triplicates as controls for complete amplification of all alleles from both reference 
samples mixed in equal proportions (data not shown). R120 and R60 male genomic DNA were used in this 
t d  
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Genotypes from mixtures of 1:10 were detectable, but not without exception. The minor 
alleles (at D19S433, vWA and D8S1179 locus) were either filtered away as it fell below the 
stutter threshold of the locus or the alleles were not detectable or under the detection 
threshold set at 50 RFU (at TH01, D13S317 and DYS390). Therefore, when evaluating 
minor component alleles that fell in the stutter position of a major component, minor allele 
from 1:10 mixtures could be mistakenly filtered as stutters, which indicates the lower limit 
of mixture detection for Miniplex 2.  From the mixture studies, Miniplex 1 appeared to be a 
more robust assay in resolving DNA mixtures than Miniplex 2. The use of Y-STRs, 
DYS392 in Miniplex 1 and DYS390 in Miniplex 2 also demonstrate its usefulness in 
determining the number of male contributors in a mixed DNA profile. 
 
6.   Species Specificity  
 
  A range of animals were tested on both Miniplex 1 and 2. Amplification was observed 
mainly in primates, which included silver leaf langur, siamang, goeldies monkey, macaque, 
orang utan, long tail macaque, baboon, saki monkey, chimpanzee, gibbon, proboscis 
monkey, black howler monkey, javan langur, black spider monkey and douc langur. For 
minplex 1, only the slow loris did not show any amplification products, while 11 loci were 
amplified for the chimpanzee DNA. For Miniplex 2, silver leaf langur, goeldies monkey, 
slow loris, saki monkey, proboscis monkey, javan langur, black howler monkey and douc 
langur did not show any amplifications, while 6 loci were amplified for the chimpanzee 
DNA. Non-primate DNA included water buffalo, spotted hyena, Egyptian goose, German 
shepherd, red dhole, chicken, pig, goat, fish, pot-bellied pig and golden cat. For Miniplex 1, 
approximately, 72 to 79-bp sized 6-FAM fragments, which appeared as a single or three 
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distinct fragments and at reduced peak heights (<100 RFUs), at where the SRY and 
Amelogenin genotypes were expected. This peaks appeared in all mammals except the 
golden cat that are tested. These fragments can be attributed to SRY gene being conserved 
in all therians (Veyrunes et al. 2008), or a monomorphic product amplified from certain 
mammals by the amelogenin primers (Buel et al.1995). Three low level non-specific 6-FAM 
fragments, were found in german shepherd, red dhole and fish. The fragment size for 
german shepherd and red dhole, both canines were identical, at 124 bp while for the fish, at 
120 bp. Both fragments were found within the D2S1338 alleles range and were marked as 
off-ladder alleles. Two low level VIC-fragments, sized at 177 and 199-bp were detected in 
spotted hyena and labeled as D7S820 allele 15 and D13S317 allele 12, respectively. No 
amplification products were detected for non-primates in Miniplex 2. The remainder of the 
tested species exhibited no amplification (chicken, golden cat, P. aeruginosa, E. coli, 
microbial pool and lambda DNA). Representative electropherograms for several species are 
illustrated in Figure 27.  
 
  Though amplification were observed in several non-primate species, the results were not 
surprising for mini-STRs as Opel and co-workers observed (Opel et al. 2007) observed 
amplification for D16S539 and D13S317 in non-human species. Amplification from non-
human species, included primates could pose potential intepretation difficulties. The non-
specific amplicons are documented and would serve as useful references when non-expected 
alleles appear in amplification. None of the non-human species were able to generate a full 
DNA profile using both miniplex assays, even for chimpanzee, and several loci are off-




















Figure 27. Representative results from a species specificity stud.  Miniplex 1 (panels on left) and Miniplex 2 (panels on right). Arrow 
indicate the 124-bp size fragment artefact in caine DNA. 
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7. Standard specimens, concordance, reproducibility and population studies  
   All samples regardless of extraction technique used by the laboratory produced consistent 
and reproducible results with the Miniplex sets. NIST SRM 2391b, the PCR-based DNA 
profiling standard produced full concordance using the miniplex assays using Genomic 1 to 
8 and G9947 DNA standards. In addition, 9948 and 007 male control DNA, which is 
standard positive controls for Promega and Applied Biosystems human identification 
multiplex kits were genotyped and full concordance was observed. This indicated the 
reporduciblity of both multiplexes. For FTA punch size of 1.2mm, the PCR cycle was 
adjusted from 30 cycles to 26 cycles in order to prevent over-amplification and causing the 
over-saturation of the charge coupled device (CCD) detector.  
  Miniplex 1 and 2 primer sets were earlier tested with a different buffer and enzyme 
combination i.e. Promega GoldS*TR and AmpliTaq Gold® DNA polymerase. PCR 
conditions were slightly different to the current miniplex assay, with annealing temperature 
set at 55oC for 1 minute and extension at 72oC for 1 minute, in constrast to 59oC for 2 
minutes of annealing and 74oC for extension for 1 minute in the present set-up. 238 Chinese, 
241 Malays and 243 Indians for Miniplex 1, while for Miniplex 2, 249 Chinese, 244 Malays 
and 248 Indians were earlier genotyped. Since the same primer sets were used, a subset of 
the earlier samples was taken to be re-genotyped with the current miniplex assay for 
concordance. For Miniplex 1, 83 Chinese, 78 Malays, 82 Indians were re-genotyped while 
for Miniplex 2, 81 Chinese, 77 Malays and 90 Indians were re-genotyped using the present 
miniplex assays. The results are summarised in Table 11. 
     No discordant results were observed among the Chinese either for the gender or STR loci 
in both miniplex assays. For Malays, there were 25 discordant D7S820 allele calls out of 78  
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 Locus Origin Identifiler *Miniplex 1,2 Miniplex 1,2 Likely Cause 
1. D7S820 Malay 8.12 8,12 12,12 Allele 8 primer binding mutation 
2. D7S820 Malay 9,11 9,11 11,11 Allele 9 primer binding mutation 
3. D7S820 Malay 8,11 8,11 11,11 Allele 8 primer binding mutation 
 D16S539  8,9 9,9 9,9 Allele 8 primer binding mutation 
4. D7S820 Malay 8,11 8,11 8,8 Allele 11 primer binding mutation 
5. D7S820 Malay 8,10 8,10 10,10 Allele 8 primer binding mutation 
6. D7S820 Malay 11,12 11,12 11,11 Allele 12 primer binding mutation 
7. D7S820 Malay 8,10 8,10 10,10 Allele 8 primer binding mutation 
8. D7S820 Malay 8,11 8,11 11,11 Allele 8 primer binding mutation 
9. D7S820 Malay 8,11 8,11 11,11 Allele 8 primer binding mutation 
10. D7S820 Malay 8,11 8,11 11,11 Allele 8 primer binding mutation 
 Amelogenin  X,X X, X X, X SRY, DYS390 and DYS392 alleles detected. Amel Y primer 
binding mutation or Yp11.2 deletion. 
11. D7S820 Malay 8,11 8,11 11,11 Allele 8 primer binding mutation 
12. D7S820 Malay 8,10 8,10 10,10 Allele 8 primer binding mutation 
13. D7S820 Malay 8,12 8,12 12,12 Allele 8 primer binding mutation 
 Amelogenin  X,X X,X X,X SRY, DYS390 and DYS392 alleles detected. Amel Y primer binding mutation or Yp11.2 deletion. 
14. D7S820 Malay 9,11 9,11 11,11 Allele 9 primer binding mutation 
15. D7S820 Malay 8,10 8,10 10,10 Allele 8 primer binding mutation 
16. D7S820 Malay 8,12 8,12 12,12 Allele 8 primer binding mutation 
17. D7S820 Malay 8,12 8,12 12,12 Allele 8 primer binding mutation 
18. D7S820 Malay 10,11 10,11 11,11 Allele 10 primer binding mutation 
19. D16S539 Malay 8,9 9,9 9,9 Allele 8 primer binding mutation 
20. D7S820 Malay 11,12 11,12 11,11 Allele 12 primer binding mutation 
Table 11. Summary of 53 discordant STR profiling results observed in this study between Identifiler kit and our Miniplex assays 
for 34 Malays and 19 Indians. No discordant results for Chinese. * denotes miniplex assays using Promega GoldST*R buffer and 





 Locus Origin Identifiler *Miniplex 1,2 Miniplex 1,2 Likely Cause 
21. D7S820 Malay 8.11 8,11 11,11 Allele 8 primer binding mutation 
 D16S539  8,13 13,13 13,13 Allele 8 primer binding mutation 
22. D7S820 Malay 10,11 10,11 10,10 Allele 11 primer binding mutation 
23. D7S820 Malay 8,11 8,11 8,11 Allele 8 primer binding mutation 
24. D7S820 Malay 8,12 8,12 12,12 Allele 8 primer binding mutation 
25. D7S820 Malay 9,11 9,11 11,11 Allele 9 primer binding mutation 
26. D7S820 Malay 8,11 8,11 11,11 Allele 8 primer binding mutation 
 D16S539  8,10 10,10 10,10 Allele 8 primer binding mutation 
27. D16S539 Malay 8,11 11,11 - Allele 8 primer binding mutation 
28. Amelogenin Malay X,X X,X - SRY, DYS390 and DYS392 alleles detected. Amel Y primer 
binding mutation or Yp11.2 deletion. 
29. D16S539 Malay 8,12 12,12 - Allele 8 primer binding mutation 
30. D16S539 Malay 8,9 9,9 - Allele 8 primer binding mutation 
31. D16S539 Malay 8,13 13,13 - Allele 8 primer binding mutation 
32. D16S539 Indian 8,11 11,11 11,11 Allele 8 primer binding mutation 
33. Amelogenin Indian X,X X,X X,X SRY, DYS390 and DYS392 alleles detected. Amel Y primer 
binding mutation or Yp11.2 deletion. 
34. D16S539 Indian 8,12 12,12 12,12 Allele 8 primer binding mutation 
35. D16S539 Indian 8,12 12,12 12,12 Allele 8 primer binding mutation 
36. D16S539 Indian 8,12 12,12 12,12 Allele 8 primer binding mutation 
37. D16S539 Indian 8,10 10,10 10,10 Allele 8 primer binding mutation 
38. D16S539 Indian 8,11 11,11 11,11 Allele 8 primer binding mutation 
39. D16S539 Indian 8,10 10,10 10,10 Allele 8 primer binding mutation 
40. D16S539 Indian 8,11 11,11 11,11 Allele 8 primer binding mutation 




Table 11: Continue. 
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 Locus Origin Identifiler *Miniplex 1,2 Miniplex 1,2 Likely Cause 
42. Amelogenin Indian X,X X,X - SRY, DYS390 and DYS392 alleles detected. Amel Y primer 
binding mutation or Yp11.2 deletion. 
43. D16S539 Indian 8,13 13,13 - Allele 8 primer binding mutation 
44.. Amelogenin Indian X,X X,X - SRY, DYS390 and DYS392 alleles detected. Amel Y primer 
binding mutation or Yp11.2 deletion. 
45. D16S539 Indian 8,11 11,11 - Allele 8 primer binding mutation 
46. D16S539 Indian 8,11 11,11 - Allele 8 primer binding mutation 
47. D16S539 Indian 8,11 11,11 - Allele 8 primer binding mutation 
48. TPOX Indian 8,11 8,8 - Allele 11 primer binding mutation 
49.. Amelogenin Indian X,X X,X - SRY, DYS390 and DYS392 alleles detected. Amel Y primer 
binding mutation or Yp11.2 deletion. 
50. D16S539 Indian 8,12 12,12 - Allele 8 primer binding mutation 
51 D16S539 Indian 8,11 11,11 - Allele 8 primer binding mutation 
52. D16S539 Indian 8,12 12,12 - Allele 8 primer binding mutation 
53. D16S539 Indian 8,14 14,14 - Allele 8 primer binding mutation 
54. DYS390 Malay - Null Null Primer binding mutation 









Table 11: Continue. 
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Malay samples between the present Miniplex 1 and Identifiler, while the previous Miniplex 1 did 
not show any discordant D7S820 allele calls. This difference was due to annealing temperatures 
between the two miniplex 1 assays as the present primer set used 59oC as the annealing 
temperature, and not the lower 55oC annealing temperature used in the earlier assay. This 
observation is consistent with reports that have demonstrated recovery of null or imbalance alleles 
in multiplex when annealing temperature were lowered (Forrest et al. 2004, Leibelt et al. 2003).  
Out of the 25 discordant D7S820, 17 were for allele 8, indicating that the primer binding mutation 
is closely linked with the allele. The primer mutation at D7S820 was observed only among 
Malays. This same phenomenon has been reported for D8S1179 locus in Chamorros and Filipinos 
from Guam were found to have primer binding mutation using Profiler Plus multiplex assay from 
Applied Biosystems with 5/68 Chamorros and 8/72 Filippino samples being affected resulting in 
false homozygotes (Budowle et al. 2001). For D7S820, 25/77, or 32% of the samples genotyped 
has false homozygosity. This percentage is of concern as discordance can result in mis-
identification when different multiplex assays are utilized. To overcome the non-binding primer, a 
second amplification can be performed using a lower annealing temperature or degenerate primers 
that have offset the primer binding mutation can be added to Miniplex 1 primer set. This will 
require the D7S820 loci to be sequenced in order to identify the base mutation responsible for the 
null allele. For D8S1179 in Chamorros and Filipinos populations, an extra primer to account for 
the variant primer binding site was added to the Profiler Plus primer set without any deleterious 
impact on the genotyping (Leibeit et al. 2003). Alternatively a lower annealing temperature of 
55oC or even lower can be used to recover the null allele.  
  Discordant genotype at D16S539 locus was also observed. Using Miniplex 1, 8 out of 241 (3%) 
Malays and 17 out of 243 (7%) Indians regardless of the current or previously utilized minplex 
assays were found to have a null allele 8 when compared with Identifiler genotypes. Similarly to
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D7S820, the same approach of adding additional primers to include the variant primer binding 
locations can be used to resolve the false homzygosity at D16S539 or amplification. For D16S539, 
it appeared that the variant primer binding mutation is specific for allele 8 unlike D7S820 which 
includes other alleles and the mutation is most likely at the 3’ terminal end of the primer sequence 
since as using both annealing temperatures of 55oC and 59oC, allele 8 was not genotyped. This 
possiblity would require confirmation by sequencing. One instance of discordant null allele in 
TH01, TPOX and DYS390 in the STR loci were observed in the concordance studies, which 
would be due to primer mutations at the binding site on the DNA template. 
  For amelogenin, discordant gender was found in 3 out of 210 (1.4%) Malay males and 4 out of 
219 (1.8%) Indian males, when DNA profiles were compared between Identifiler and the miniplex 
assays.  All the samples in Identifiler were mistyped as females while both miniplex assays 
correctly identified as males. The miniplex assays, which use a panel of Y-specific markers, 
namely SRY, amelogenin (different primer set from Identifiler) and Y-STRs (DYS390 and 
DYS392) enabled reliable gender genotyping. Identifiler and other commercially available STR 
typing kits based gender identification singularly on the amelogenin test. 
  Reliable gender identification is important in forensic investigations as wrong gender information 
could mislead investigators as well as mis-identification of mass disaster victims. Amelogenin 
nulls have been reported among Malays and especially for Indians. Chang and co-workers (2003) 
have reported 1 out of 113 Malays and 4 out of 112 Indians in Malaysia having amelogenin Y 
nulls. Cadenas and co-workers (2007) have reported 5 out of 77 Kathmandu males having dropout 
of the amelogenin Y allele while Thangaraj et al. 2002 reported 1.85% of Indians have amelogenin 
deletions. Our laboratory had also observed amelogenin null among Bangladeshi, Chinese and 
Malay individuals (Lim et al. 2005). A more recent report by Chang and co-workers (2007) found 
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3.2% of Indians and 0.6% of Malays are amelogenin Y negative males. Similar amelogenin nulls 
were reported in Australia (Roffey et al. 2000), Austria (Steinlechner et al. 2002), Israeli (Michael 
and Brauner 2004) and Japanese (Takayama et al. 2009) populations. Most of the reports indicated 
the null amelogenin Y genotype due to Yp11.2 deletions involving the amelogenin gene, and to a 
much lesser extent, primer binding mutation. 
  Additional Y-specific markers have been used to confirm gender in forensic investigations. This 
inclued SRY (Kastelic et al. 2009), 2 different amelogenin primer sets in combination with SRY 
(Esteve Codina et al 2009), Y-STRs (Takayama et al. 2009, von Wurmb-Schwark et al. 2009) or a 
combination of the three approaches (Lim et al. 2005). In this study, the employment of SRY, 
alternative amelogenin primer sets and 2 Y-STR specific loci DYS390 and DYS392 produced 
reliable male gender identification. Full concordance between Identifiler and both miniplex assays 
was observed in 99.8% (24,878 out of 24,928) allele calls compared. SRY, DYS390, DYS392 and 
D2S1776 were not compared since these markers are not found in Identifiler. 
  For population studies, Identifiler STR markers were not examined since the population studies 
for these markers have been completed (Budowle, 2004, Syn et al., 2005, Ang et al. 2005 and Lim 
et al. 2005). For DYS390 and DYS392, the population data of Singapore was also published 
(Budowle et al.  2009, Tang et al. 2006). D2S1776 was examined using PowerStats and the 
summary of the population studies is summarized in Table 12. Based on the heterozygosity values 
of 78.5%, 63.8% and 69.5% among the Chinese, Malay and Indian, D2S1776 is comparable to the 
heterozygosity values for STR markers in Identifiler®. (Ang et al. 2005, Budowle et al. 2009, Lim 
et al. 2005, Syn et al. 2005) 
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Locus: D2S1776      
  Chinese Malay Indian     
Forensic       
  Matching Probability 0.068 0.148 0.127  
 
Expressed as 
1 in ... 14.7 6.8 7.9  
  Power of Discrimination 0.932 0.852 0.873  
  PIC  0.77 0.64 0.66  
Paternity       
  Power of Exclusion 0.572 0.339 0.420  
  Typical Paternity Index 2.33 1.38 1.64  
Allele Frequencies      
  Homozygotes 21.5% 36.2% 30.5%  
  Heterozygotes 78.5% 63.8% 69.5%  
  Total Alleles 494 492 498  
       
 Allele         Frequency 
 7 0.2% 0.2%   
 8 28.7% 0.8% 2.4%  
 9 13.6% 3.9% 3.2%  
 10 15.4% 5.5% 7.4%  
 10.1  0.2%  
 11 24.5% 28.3% 31.1%  
 12 12.3% 46.3% 41.8%  
 13 4.3% 12.6% 11.6%  
 14 1.0% 2.2% 1.6%  









Table 12. Summary of D2S1776 population statistics using PowerStats. 
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8. Simulated Forensic Samples 
  Our laboratory had previously prepared mock forensic samples for validation of a DNA 
extraction protocol using Promega Maxwell® 16 DNA extraction system (Lim et al. 2009).  
In addition, unused samples from our external proficiency testing were also used. Organic 
extracted DNA from these samples was amplified to evaluate Miniplex 1 and 2 performance in 
comparison to the genotypes obtained using Identifiler®. The summary of the results are found in 
Table 13.  A total of 76 samples were examined, which comprised of liquid blood, cigarettes, 
bloodstains on cloth, leather, shirt, soil, blue denim jeans and swabs stained with semen.   
  From table 13, 44 out of the 74 samples genotyped, full DNA profiles were obtained using 
Identifiler®. Similarly, Miniplex 1 and 2 were able to obtain complete DNA profile. The DNA 
profile from the remaining 30 samples were found to have either partial or no DNA profile was 
obtained using Identifiler. Of these samples, 6 out of 30 samples managed to produce full DNA 
profiles using both Miniplex 1 and 2. With the exceptions of 5 samples obtained from soil, which 
did not generate any DNA profiles, the remaining samples recovered more alleles using Miniplex 
1 and 2 than Identifiler®. The results demonstrated that Miniplex 1 and 2 were able to obtain 
significantly more alleles than Identifiler®, when samples are present in low quantity, degraded 
and inhibited. The non-amplification from soil is either due to high inhibitor concentration or DNA 
is fully degraded. 
  However, abnormalities that were unexpected were encountered in 4 samples that did not yield 
any DNA profile using Identifiler®. Though successful genotyping were obtained using Miniplex 1 
and 2, there were non-specific amplification products using Miniplex 1.These 4 samples shared 
one thing in common in that using Identifiler®, these samples showed non-amplification, most 
likely due to the presence of high amounts of inhibitors in the DNA extracts. For samples derived 
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 Sample Marking 
Type of Sample 
No of loci detected / No of loci in multiplex 
assay Remarks 
Identifiler Miniplex 1 Miniplex 2 
Item_ 1_ 031007 Blood Stain on Cloth 16/16 10/10 8/8  
Item_ 2_ 031007 Blood Stain on Cloth 16/16 12/12 9/9  
Item_ 3_ 031007 Blood Stain on Cloth 16/16 10/10 8/8  
Item_ 4_ 031007_Counch Stain Blood Stain on Cloth 16/16 12/12 9/9  
BIS18_031007 Blood Stain on Cloth 16/16 10/10 8/8  
Item_1_090707 Blood Stain on Cloth 16/16 10/10 8/8  
Item_2_090707 Blood Stain on Cloth 16/16 12/12 9/9  
Item_3_090707_MF Blood and Semen Stain on Cloth 16/16 12/12 9/9  
Item_3_090707_FF Blood and Semen Stain on Cloth 16/16 12/12 9/9  
Item_4_090707 Blood Stain on Cloth 16/16 12/12 9/9  
Item_ 1_ 080107 Blood Stain on Cloth 16/16 10/10 8/8  
Item_ 2_ 080107 Blood Stain on Cloth 16/16 12/12 9/9  
Item_ 3_ 080107 Blood Stain on Cloth 16/16 12/12 9/9  
Item_4_080107 Blood Stain on Cloth 16/16 12/12 9/9  
BIS17_080107 Blood Stain on Cloth 16/16 10/10 8/8  
Item_1_290307 Blood Stain on Cloth 16/16 10/10 8/8  
Item_2_290307 Blood Stain on Cloth 16/16 12/12 9/9  
Item_3_290307_MF Blood and Semen Stain on Cloth 16/16 12/12 9/9  
Item_3_290307_FF Blood and Semen Stain on Cloth 16/16 12/12 9/9  
Item_4_290307 Blood Stain on Cloth 16/16 10/10 8/8  
A_Shirt Blood Stain on Shirt 16/16 12/12 9/9  
B_Shirt Blood Stain on Shirt 16/16 10/10 8/8  
C_Shirt Blood Stain on Shirt 16/16 10/10 8/8  
D_Shirt Blood Stain on Shirt 16/16 10/10 8/8  
E_Shirt Blood Stain on Shirt 16/16 12/12 9/9  
Table 13. Summary of simulated casework genotyped using Miniplex 1 and Miniplex 2. For Miniplex 1, if sample is of female origin, 
only 10 loci can be genotyped since SRY and DYS392 are male specific loci. For Miniplex 2, if sample is of female origin, 8 loci can be 
genotyped since DYS390 are male specific loci. Samples that were not tested were due to insufficient DNA extract. Samples with allele 
dropouts using Identifiler are bold. 
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Sample 
Marking Type of Sample 
No of loci detected / No of expected loci in 
multiplex assay Remarks 
Identifiler Miniplex 1 Miniplex 2 
A_Leather Blood Stain on Leather Belt 16/16 12/12 9/9  
B_Leather Blood Stain on Leather Belt 16/16 10/10 8/8  
C_Leather Blood Stain on Leather Belt 16/16 10/10 8/8  
D_Leather Blood Stain on Leather Belt 16/16 10/10 8/8  
E_Leather Blood Stain on Leather Belt 16/16 12/12 9/9  
R20 Liquid Blood 16/16 12/12 9/9  
R21 Liquid Blood 16/16 10/10 8/8  
R29 Liquid Blood 16/16 10/10 8/8  
R30 Liquid Blood 16/16 10/10 8/8  
R31 Liquid Blood 16/16 10/10 8/8  
R34 Liquid Blood 16/16 10/10 8/8  
R36 Liquid Blood 16/16 10/10 8/8  
R39 Blood stain on Cloth 16/16 10/10 8/8  
R40 Blood stain on Cloth 16/16 10/10 8/8  
C1_20-1 Cigarette Butt 16/16 12/12 9/9  
C2_20-1 Cigarette Butt 16/16 12/12 Not Tested  
C7_24-1 Cigarette Butt 16/16 10/10 8/8  
C8_24-1 Cigarette Butt 16/16 10/10 8/8  
A50x20_1 Blood diluted 50x and stained 
  
11/16 10/12 9/9  
A100x20_1 Blood diluted 100x and stained 
  
3/16 11/12 9/9  
A500x_20_1 Blood diluted 500x and stained 
  
0/16 9/12 9/9  
B500x20_1 Blood diluted 500x and stained 
  
5/16 9/10 8/8  
 
 
Table 13. Continued. 
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Sample 
Marking Type of Sample 
No of loci detected / No of expected loci in 
multiplex assay Remarks 
Identifiler Miniplex 1 Miniplex 2 
A_Shirt_20_1 Blood stain on shirt 13/16 12/12 9/9  
A_Denim_20_1 Blood stain on blue jeans 0/16 12/12 9/9 ~209 bp sized FAM fragment 
detected in Miniplex 1                     
~168 bp VIC sized fragment 
detected in Miniplex 1 
B_Denim_20_1 Blood stain on blue jeans 0/16 8/10 4/8 ~112 bp and 132 bp sized FAM 
fragments detected in Miniplex 1                      
C_Denim_20_1 Blood stain on blue jeans 0/16 10/10 8/8  
D_Denim_20_1 Blood stain on blue jeans 0/16 10/10 8/8  
E_Denim_20_1 Blood stain on blue jeans 0/16 9/12 2/9 ~123 bp and 209 sized FAM 
fragments detected in Miniplex 1                                                 
~168 bp VIC sized fragment 
detected in Miniplex 1 
A_Soil_20_1 Blood stain on soil 0/16 0/12 0/9  
B_Soil_20_1 Blood stain on soil 0/16 0/10 0/8  
C_Soil_20_1 Blood stain on soil 0/16 0/10 0/8  
D_Soil_20_1 Blood stain on soil 0/16 0/10 0/8  
E_Soil_20_1 Blood stain on soil 0/16 0/10 0/8  
C3_20_1 Cigarette Butt 11/16 12/12 Not Tested  
C4_20_1 Cigarette Butt 12/16 12/12 9/9  
C5_20_1 Cigarette Butt 15/16 12/12 9/9  
C6_24_2 Cigarette Butt 12/16 12/12 9/9  
C9_24_2 Cigarette Butt 0/16 12/12 Not Tested ~168 bp sized VIC fragment 
detected in Miniplex 1                                                  
~170 bp sized NED fragment 
detected in Miniplex 1 


























Figure 28. Non-specific amplification fragments of simulated casework samples that are highly inhibited. The non-specific 






from denim jeans, indigo blue dye is known to be an inhibitor of PCR (Shutler et al. 1999). For 
cigarette, it is likely the presence of humic acid or tanic acid from tobacco material that would 
have cause PCR inhibition (Tsai et al. 1992 and Watson and Blackwell et al. 2000), however the 
nature of inhibitors present were not ascertained though the presence of inhibitors were indicated 
by the data obtained from Quantifiler®. The artifacts of the 4 samples are highlighted in the 
electrophoregrams in Figure 28. 
  The use of Miniplex 1 managed to obtain a full or partial DNA profile but the occurrence of 
unexpected fragments posed issues towards interpretation of the DNA profiles. Two of the 
fragments were reproducible, namely the 209 and 168 – bp sized fragments in 6’FAM and VIC 
panels, which would allow easy identification with its appearance in inhibited DNA samples. 
The 123 bp sized 6’FAM fragment is the most disconcerting as it was assigned allele 28.2 in the 
D21S11 locus. The remaining fragments are found at 112, 169 and 132 bp position in 6’FAM 
panel, while the 170 bp sized fragment were found in the NED panel. All these fragments are 
off-ladders and were found within the loci D2S1338, D21S11, D7S820 and D18S51. Their 
appearance could be due to several reasons. One of which could be the presence of strong 
inhibitors which could have a detrimental effect on the specificity of the OmniTaq Polymerase 
though this non-specific amplification was not observed in Miniplex 2. OmniTaq Polymerase is 
a mutant Taq polymerase at codon 708, which conferred enhanced
 resistance to various inhibitors (Kermekchiev et al. 2009). This mutation might under inhibitory 
conditions compromise its specificity though tests would need to be performed to determine this. 
In addition, Miniplex 1 had more loci being amplified than Miniplex 2 and there were more 
primer to primer interactions and this could be a contributory factor why non-specific 
amplification appeared under severe inhibitory conditions with unknown inhibitors. As studies 
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have been carried out on common inhibitors without any artifacts being formed, the appearance 
of these fragments might also be due to other factors, which needed to be studied and solutions 
can then be proposed for its remedy. The STR loci that were affected, namely D2S1338, 
D21S11, D7S820 and D18S51 should be interpreted with caution and verification procedures 
such as re-amplification or alternative primer set amplification can be performed to establish the 
true alleles whenever it is encountered. Mixture intepretation would pose as a problem as 
accurate intepretation would be difficult with non-specific fragments appearing. Miniplex 2, 
however did not encounter such non-specific fragments which indicates its reliabilty and ease of 
intepretation. Though the non-specific amplifications in Miniplex 1 would make intepretation 
difficult, the ability to amplify highly inhibited samples would still be useful for human 
identification, and with careful interpretation, also be useful genotype information could still be 
obtained. 
  
3. Initial Development of Miniplex C 
Multiplex genotyping produced DNA profile of similarly sized amplicons being resolved by 
having large size differences (~100 bp to 400 bp) and being tagged by different fluorescent dyes. 
The development of a 5 dyes system from a 4 dye system have allowed more similarly sized 
amplicons to be genotyped. The 5-dye system can accommodate 4 identically sized fragments 
resolved by the 4 dye colours, the remaining color acting as an internal size standard. However, 
when degraded DNA is encountered, amplicons size would need to be reduced to accommodate 
the smaller available DNA template for amplication. This has resulted in miniSTR primers being 
proposed and developed into several miniplexes in order to cover all CODIS markers (Bulter et 
al. 2003). The use of multiple miniplexes is not always favourable when limited amount of DNA 
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is available and with degraded DNA, as identical small-sized amplicons of less than 200 bp were 
produced. This makes the fragment size identical in lengths and several miniplexes are needed to 
gather enough STR genotypes for useful identification since they occupy the same size window 
and the only course of resolution is by dye-color. Hence, if more miniSTR primers produced 
amplicons can be resolved in single genotyping attempt; this would circumvent the limitation 
imposed by the amount of DNA available.  
  In order to increase the resolving ability of the multiplexes, a novel solution was proposed. The 
forward primer set for Miniplex 1 was modified to contain an internal Uracil which replaced a 
Thymine nucleotide in the primer sequence. The forward primer set for Miniplex 2 was modified 
to contain an internal Inosine which replaced a Thymine nucleotide in the primer sequence. The 
use of a Uracil or Inosine specific cleavage enzyme would remove amplicons produced by 
Miniplex 1 or Miniplex 2, respectively. This approach would double the number of STR loci 
with identical sized amplicons being genotyped in a single amplification. Suitable cleavage 
enzymes were tested and eventually USERTM enzyme, a Uracil specific cleavage enzyme and 
Thermotoga maritima thermastable endonuclease V, an Inosine specific cleavage enzyme were 
selected. E. coli endonuclease V were also tested but was dropped due to its non-specificity in 
cleaving inosine-containing amplicons as uracil-containing amplicons were partially cleaved, 
resulting in reduced signal strength (data not shown). The flow diagram of this new approach is 
shown in Figure 29. 
  A total of 9 samples were tested in using this approach. Samples include 9947, 9948, 007 and 6 
DNA extracts from neat blood samples were utilised to determine the viablity of this approach. 
All 9 samples showed that co-amplication using both Miniplex 1 and 2 is viable and cleaving an 
aliquot of 5 µl of PCR product with either USERTM enzyme or Endonuclease V enzyme,  
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 Figure 29. Flow diagram of the genotyping strategy used by Miniplex C. Miniplex C uses both Miniplex 1 and 2 primer sets in 1 
PCR amplification reaction. To genotype each set, either USERTM enzyme or Endonuclease V is added. When USERTM enzyme is 
added, only inosine containing amplicons would be genotyped and When Endonuclease V is added, only uracil containing 






Figure 30. Panel A: Miniplex 1 and 2 comamplified using R60 male genomic DNA. Amplicons overlapped with STR loci with 
similar size fragments for each fluorescent dyes. Panel B: 5 µl of PCR products were aliquoted and Endonuclease Venzyme were 
added and only PCR products generated by Miniplex 1 was genotyped. Panel C: 5 µl of PCR products were genotyped and only 
PCR products generated by Miniplex 2 were genotyped. 
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produced the desired Miniplex 1 or Miniplex 2 DNA profiles. An example is shown in 
Figure 30. The DNA profiles generated were characterised with numerous spectral bleed-
throughs as a matrix to deconvolute each fo the dye colours used in the forward primers 
for the multiplexing were not available and thus were not performed. 
  Futher validation would be required in order to apply Miniplex C to casework samples. 
For a start, a matrix or spectral calibration would need to be performed on the genetic 
analyser system before further validation tests, similar to this study that was performed 
for Miniplex 1 and 2 would be required. The feasiblity tests that were done, indicated the 
viablity of this novel approach. The success of which meant that more genotype results 
can be obtained from highly degraded DNA samples and genotyping more amplicons 
with identical sizes in one amplification attempt. 
 
10. Conclusion 
  This study was performed using the validation guidelines as specified by SWGDAM. 
Miniplex 1 and 2 contain all CODIS markers in addition to D2S1338, D19S433 and 
D2S1776 and gender specific markers, SRY, DYS390 and DYS392. The approach 
allowed an effective tool for the analysis of degraded DNA samples and also highly 
reliable gender identification. The developmental validation study demonstrates the 
robustness, sensitivity, stability and reproducibility of the miniplex assays. For Miniplex 
1, where PCR inhibitors are present in high concentration, caution should be exercised 
during interpretation.  The studies did demonstrate that Miniplex 2 would provide reliable 
genotyping under inhibitory conditions. Perhaps fewer STR loci in a multiplex could be 
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utilized to reduce the number of primer to primer interaction, using the same PCR buffer 
and enzyme combinations to prevent non-specific amplifications in inhibitory conditions. 
Alternative primers could also be tested. Another approach could be the use of other 
DNA polymerases that have similar properties as OmniTaq being reported (Hedman et 
al. 2009).  The studies however did show the use of OmniTaq and EzWay Direct PCR 
buffer to be extremely robust in overcoming amplification inhibitors and would still be a 
good PCR system to consider with other primer sets such as the non-codis multiplex that 
our laboratory has developed. 
  Recommendations for routine laboratory process were also established as a result of this 
study, where using 250 – 500 pg of DNA with 30 cycles of PCR would produce complete 
DNA profiles with good peak balance. Allele concordance studies demonstrated that 
D7S820 and D16S539, would require additional degenerate primers to offset the primer 
mutations found in the Malay and Indian population groups would need to be addressed.  
These studies provided important data for our laboratory to assess the suitability of the 
Miniplex sets under a variety of conditions that may arise in the interpretation of data 
from complex forensic samples. Further tests could be conducted to non-routine forensic 
samples such as hair, fingernail scrapings, bone-extracted DNA samples. As both 
miniplex assays are shown to work well with degraded and low copy number samples, it 
is anticipated using these primer sets for these samples would improve genotyping 
success rates. 
  Miniplex C demonstrated a novel concept of forensic DNA typing approach. This 
approach, when fully validated would mean that future genotyping of limited quantity of 
degraded DNA would yield more STR genotype in one given amplification attempt. The 
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initial success indicated that this approach should be futher evaluated in order to achieve 
a highly desirable outcome in forensic DNA typing. 
  In conclusion, this project and the validation tests done showed that Miniplex 2 is a 
robust and reliable tool which can provide an alternative to standard STR typing kits 
under inhibitory conditions and when allele drop out and low sensitivity of large 
amplicons becomes a problem due to DNA degradation. For Miniplex 1, the application 
to high inhibited samples must be interpreted with caution in view of the non-specific 
amplification that was encountered during the validation studies. The success of this 
project has enabled our laboratory to obtain useful genotype information from what 
would be otherwise samples that are un-amplifiable under our existing technology.  This 
new approach could be extended to other forensic DNA laboratories as Miniplex C has 
shown great potential in charting a new strategy towards how forensic DNA typing 
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